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Despite major advances in our understanding of the biochemical pathways of thrombus 
formation, our knowledge of the biophysical mechanisms that regulate thrombus growth remains 
limited. Explicitly, there is a paucity of data on how hemodynamics affects the physical 
properties of thrombi. The objective of this thesis is to measure and model the physical 
properties of thrombi as a function of the relative and absolute density of the blood cell platelets 
and the biopolymer fibrin. 
A series of thrombi were made with known fibrin and platelet densities. The permeability 
was calculated by measuring the interstitial fluid velocity through the thrombi at a constant 
pressure gradient. Hindered diffusivity was measured using a diaphragm diffusion cell and 
fluorescence recovery after photobleaching. The elastic regimes of fibrin gels was measured as a 
function of strain in both shear and extensional geometries and compared to nonaffine and affine 
network models. The composition and structure of thrombi formed under flow using 
microfluidics was quantified using confocal and focused ion beam scanning electron microscopy. 
The permeability of thrombi formed with a solid fraction of 0.02−0.61 ranged from 
10−1 to 10−5 µm2 and was best modeled as an array of disordered cylinders or as a Brinkman 
medium for low and high platelet densities, respectively. The diffusivity of coagulation 
zymogen-sized solutes was hindered by up to 93% over the same range and was best described 
by models accounting for both steric and hydrodynamic hindrance. Low density fibrin gels 
transition from a thermal network regime to a nonaffine mechanical to an affine mechanical 
regime with increasing strain. High density fibrin gels transition directly from a thermal to an 
affine mechanical regime. Within the thermal regime, the pore size can be predicted by the 
elastic modulus using semiflexible polymer theory providing a link between mechanics and 
 iv 
transport. Flow-formed thrombi were found be heterogeneous structures that contained up to 
65% solids by volume. 
Ultimately, these results enable the prediction of the properties of flow-formed thrombi. 
Importantly, all properties were found to be directly related to thrombus microstructure, thus 
providing a link between mechanics and transport that should prove useful in developing 
therapeutic approaches for thrombosis. 
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The circulatory system is the organ system by which cells transport the basic components 
needed for life throughout the body. Humans have a closed circulatory system in which the heart 
pumps blood through a systems of arteries, arterioles, capillaries, venules and veins allowing for 
the efficient delivery of oxygen and nutrients, and removal of metabolic waste from all parts of 
the body. Vital to the function of the circulatory system is the process of hemostasis, which 
serves to limit the loss of blood from an injury. Hemostasis enables an organism to close off 
damaged blood vessels upon trauma, to keep the blood in a fluid state, and to remove blood clots 
after the restoration of vascular integrity (1). An imbalance in hemostasis can result in either 
excessive bleeding (hemorrhage) or excessive clotting (thrombosis), which can ultimately result 
in the obstruction of blood flow through vessels. Hemorrhage can be caused by trauma, 
deficiencies of coagulation factors, deficiencies in platelet adhesion or aggregation, or 
anticoagulant and antiplatelet drugs. Thrombosis can be caused by perturbations in blood 
composition that lead to a prothrombotic state (e.g. downregulation of anticoagulation factors), 
stasis in blood flow, or rupture of atherosclerotic plaques. 
Hemostasis occurs through the intertwined processes of platelet plug formation and a 
series of biochemical reactions called coagulation, both of which are regulated by many 
biochemical and biophysical mechanisms. These reactions can reinforce or inhibit each other 
either directly or indirectly (2). Upon onset of injury endothelial cells and other blood vessel wall 
cells are removed exposing an extracellular matrix that promotes platelet adhesion and 
activation. Adhered and activated platelets aggregate with newly arriving platelets transported to 
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the injury by blood flow to form a platelet plug. Simultaneously, coagulation is initiated by 
subendothelial tissue factor and/or negatively charged surfaces (collagen, phosphatidylserine, 
polyphosphates) ultimately resulting in the generation of the serine protease thrombin, which 
serves a dual role as platelet agonist and catalyst for formation of biopolymer called fibrin. Once 
formed the hemostatic plug must stem the loss of fluid from the vessel. To accomplish this, the 
plug must be sufficiently impermeable to fluid flow and must posses the mechanical strength to 
withstand the forces imparted upon it by the flowing blood. 
The composition of thrombi is highly dependent on both the local hemodynamics and the 
nature and extent of injury. Clots formed in areas of high flow tend to be platelet rich due to the 
platelet’s ability to adhere and aggregate at high shear stresses and are characteristic of 
myocardial infarctions that form at the site of an atherosclerotic plaque rupture. Clots formed 
where blood flow is slow tend to be fibrin and red blood cell rich because coagulation reactions 
and fibrin polymerization have a greater residence time in areas of recirculating flows such as in 
venous valve pockets. Flow dynamics contribute to a number of factors that determine the 
success of the clot including platelet activation, platelet attachment and detachment, embolus 
shedding, and thrombus heterogeneities (3). For instance, Nesbitt et al., used high-resolution 
intravital imaging techniques and hydrodynamic analysis to show that platelet activation is 
primarily driven by changes in blood flow parameters with soluble agonists having only a 
secondary role (4). During platelet aggregation, diminished αΙΙbβ3 activity results in instability 
and platelet detachment in flow-formed clots (3). Coagulation has been shown to contribute to 
thrombus formation and stabilization via the flow-rate dependent protease-activated receptors 
(PAR), flow-rate dependent activation of platelets, flow-rate dependent generation of 
pro-coagulant PS exposing platelets, and flow-rate dependent clot stabilization via fibrin 
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formation (3, 5-9). Finally, flow dynamics and the effects of flow dynamics on platelet 
aggregation and coagulation have been shown to result in spatial heterogeneity for both in vitro 
and in vivo formed clots (7). Multiscale simulations have shown increased flow rates during 
thrombus growth leads to increased structural heterogeneity of the clot (10). These 
heterogeneities and their associated physical properties, in turn, determine the size and frequency 
of any emboli caused by blood-flow gradients and the likelihood of complications caused by 
thrombosis (11-13). 
Most of what is known about the physical properties of thrombi is based on clots formed 
statically and at static protein and cell concentrations. Numerous studies have been conducted to 
determine the effects of fibrin and thrombin concentration, platelet count, ionic strength, or other 
drugs concentration on clot permeability and solute transport, but have focused on concentrations 
of components less than or equal to concentrations found in plasma (14-21). Similarly, abundant 
studies have been conducted on clot elasticity and with a focus on determining the effects of 
thrombin concentration, ionic strength, and nonlinear elastic properties of clots formed at or near 
plasma concentrations of proteins, and cells (14, 15, 22-30),  As such there exists a gap in the 
knowledge base of the physical properties of thrombi representative of those formed under flow, 
which can contain significantly elevated levels of cells and proteins relative to plasma and have 
heterogeneous structures (7, 31, 32). The focus of this thesis is on measuring and characterizing 
the physical properties of thrombi as a function of their composition. In particular, I focus on the 
hydraulic permeability, hindered transport, and mechanical properties of thrombi formed over a 
wide range of platelet and fibrin concentrations to bound the possible values and present 
relationships that can be used to determine the physical properties of clots found in vivo as a 
function of clot composition.  
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Hydraulic permeability represents a material’s ability to transmit fluid. The primary use 
of permeability is in determining the average velocity at which a liquid of a known viscosity will 
flow through the porous material at a given pressure gradient. In hemostasis, measurements of 
permeability allow for the prediction of the rate at which fluid moves through the interstitial 
spaces of a clot. These predictions are important for estimating the rate at which coagulation 
enzymes/zymogens enter and leave a clot as well as for developing drug delivery strategies for 
disrupting clot formation or enhancing clot lysis. Measures of permeability also provide an 
estimate of the pore size of the material, which can in turn provide estimates of other physical 
properties such as estimates of hindered transport coefficients of molecules within the material, 
determination of transport limiting steps during the growth, arrest, and dissolution of a clot and 
estimates of mechanical properties based on the micro/nano structure of the material.  
The mechanical properties that are relevant to clot stability include the shear and elastic 
moduli when subject to extensional, compressive, or shear stresses. The shear modulus and 
elastic modulus are measures of how a material deforms when exposed to a shear and 
extensional stresses, respectively. These moduli consist of an elastic component and a viscous 
component that describe if the material deforms elastically (stress proportional to strain), 
viscously (stress proportional to strain rate), or as a combination of the two. The breaking stress 
is a measure the stress required to cause catastrophic failure of the clot. These properties 
determine, in part, whether the stress imparted by blood flow will cause the hemostatic plug to 
deform reversibly or irreversibly, or embolize. 
The specific aims of this thesis are: (1) Measure the volume fraction of the two major 
components of a clot, fibrin and platelets, in flow-formed clots. (2) Measure the effect of fibrin 
and platelet content on the hydraulic permeability and hindered diffusivity of clots. (3) Use 
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models of flow and diffusion through fibrous and porous media to identify predict the 
permeability and hindered diffusivity of clots as a function of composition. (4) Measure the 
effect of fibrin solid fraction and thrombin concentration on the mechanical properties on clots. 
(5) Measure the effects of strain on the elastic regime of clots. (6) Use models to identify the 
relevant variables that dictate solid mechanics of clots as a function of composition. (7) Connect 
the physical properties of permeability, hindered diffusivity, and mechanics based on the 
microstructure of representative blood clots. 
CHAPTER 2 provides background information including analysis of the solid fraction of 
in vivo formed clots and discussion of the current cell based models for clot formation that 
utilize transport limited reactions and permeability models. Next, a review of microfluidic 
models of thrombus formation is provided. Finally, background on previous measurements and 
models of permeability and mechanics of blood clots and their components is discussed. 
 In CHAPTER 3 we measure the effects of fibrin and platelet solid fraction on clot 
permeability and hindered diffusivity. Permeability and hindered diffusivity was shown to be a 
strong function of both fibrin and platelet density. Fibrin gels formed with solids fractions of 
0.02−0.54 have permeabilities of 10−1−10−4 µm2. Platelet rich clots formed with solids fractions 
of 0.02−0.61 have permeabilities of 10−1−10−5 µm2. Fibrin gels formed with a fiber volume 
fraction of 0.36 reduced the diffusion coefficients of 12, 29, and 54 nm solutes by 60%, 66% and 
85%, respectively. Platelet rich clots with a platelet volume fraction 0.61 reduced the diffusion 
coefficient of a 12 nm solute 93%.  The permeability of fibrin gels were shown to be best 
modeled as arrays of disordered cylinders with uniform diameters. The permeability of platelet 
rich clots was shown to be best modeled as a Brinkman medium of coarse solids (platelets) 
embedded in a mesh of fine fibers (fibrin). Taken together, our data shows that the permeability 
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of clots formed in vivo can vary by up to five orders of magnitude with pore sizes that range 
from 4 to 350 nm. These findings have important implications for the transport of coagulation 
zymogens/enzymes in the interstitial spaces during clot formation, as well as in the design of 
fibrinolytic drug strategies are discussed. 
In CHAPTER 4 we measure and characterize the elastic regimes fibrin gels as a function 
of fibrin density and strain and show how the elasticity of fibrin effects clot retraction. At low 
strains, fibrin gels were shown to act as thermal networks independent of fibrinogen 
concentration. Within the low strain regime, the mesh size of fibrin gels can be predicted by the 
elastic modulus by semiflexible polymer theory, providing a link between gel mechanics and 
interstitial fluid flow. At moderate strains, we show that low density fibrin gels act as non-affine 
mechanical networks and transition to affine mechanical networks, while high density fibrin gels 
only act as affine mechanical networks. At high strains, individual fibrin fibers stretch 
independent of fibrin fiber density. Platelets can retract low density gels by greater that 80% of 
their initial volume, but retraction is attenuated in high fibrin gels and with decreasing platelet 
density. These results suggest that the nature of deformation of fibrin gels and thrombi is a strong 
function of fibrin density, which has ramifications for the embolization and lysis of thrombi. 
In CHAPTER 5 we examine the solid fraction of flow-formed clots. Clots were formed in 
microfluidic channels under venous flow conditions and the solid fractions of platelets and fibrin 
was estimated using confocal microscopy and focused ion beam scanning electron microscopy 
(FIB-SEM). Our results show that clots formed under flow contain solid fractions much higher 
than clots formed statically. Consequently, we show a need for the analysis of the physical 
properties of clots representative of those formed in vivo; most previous studies have been 
conducted at low solids fractions not representative of flow-formed clots. 
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CHAPTER 6 summarizes the major findings and gives recommendation for future work. 
It is suggested that the effects of hindered transport on the growth, arrest, and dissolution of a 






Blood serves many physiological functions. Among them are the transport of oxygen and 
removal of metabolic waste from tissues, identifying and removing foreign bodies, and 
delivering immune cells to the site of infection. The focus of this thesis is on hemostasis, also 
known as blood clotting, and specifically the transport and rheological properties of blood clots. 
This chapter provides a brief overview of the composition and physical properties of blood and 
the hemostasis. 
2.1 Blood composition and rheology 
Blood is a dense suspension of cells in a protein-rich liquid called plasma. The cell 
fraction is made up of red blood cells (also called erythrocytes or RBCs; diameter  = 6−8 µm; 
5−6 ×106/µL), white blood cells (leukocytes or WBCs; d = 7−15 µm; 4−11 × 103/µL; < 1% v/v) 
and platelets (d = 1−2 µm; 2−4 × 105/µL; < 1% v/v). Plasma constitutes ~ 55% v/v of blood and 
is a solution of proteins, ions, and polysaccharides. RBC are by far the most numerous blood 
cell, comprising 35−50% of the volume of blood, and dictate the rheological properties of blood. 
Blood is a unique fluid in that it both shear thickens and shear thins. Shear thickening occurs at 
shear rates of less than 10 s−1 and is caused by attractive RBC-RBC interactions that form rods of 
RBCs called rouleaux. Shear thinning occurs at shear rates greater than 1000 s−1 and is caused by 
deformation of RBC. Platelet and leukocytes are forced towards the vessel wall by a process 
called margination that is caused by shear-induced diffusion due to interactions with RBC and 
the tank treading motion of the RBC membrane.  
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2.2 Thrombosis and Hemostasis 
Excessive and deficient clot formation, thrombosis and bleeding, respectively, are the 
leading cause of death in the United States (33). The processes of thrombus, or blood clot, 
formation are often grouped into three categories: hypercoagulability, endothelial injury, stasis, 
collectively known as Virchow’s triad. Hypercoagulability is an increased concentrations of 
platelets, micro particles, and pro- and anticoagulation proteins that effect the bloods ability to 
form a thrombus (1). Endothelial injury causes blood to be exposed to procoagulant surfaces 
triggering platelet plug and fibrin formation. Stasis is abnormally slow or stopped blood flow and 
contributes to coagulation by the accumulation of clotting factors at a single location and through 
endothelial activation derived from hypoxic conditions in the stagnant blood.  
Thrombus formation can vary greatly with location within the circulatory system. The 
composition of a blood clot depends on the local blood flow velocity, the nature and extent of the 
injury, and the vascular bed of the injury. In the large arteries where blood flow is fast, clots tend 
to be platelet rich because the platelets can adhere and aggregate at high shear stresses whereas 
coagulation products tend to be diluted. These ‘white clots’ are characteristic of myocardial 
infarctions that form at the site of an atherosclerotic plaque rupture. In the veins of the 
extremities where blood flow is slow and in areas of recirculating flows such as in venous valve 
pockets, clots tend to be fibrin and red blood cell rich because coagulation reactions and fibrin 
polymerization have a greater residence time. In these areas, the fibrin entrains red blood cells to 
give what are referred to as ‘red clots’. However, this white clot/red clot terminology 
oversimplifies the structure of the clot since both types of clots contain both platelets and fibrin, 
just in different relative densities. Clot composition is also highly heterogeneous. Clots formed in 
large vessels have a laminate structure consisting of a series of platelet-rich and fibrin-rich layers 
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known as the lines of Zahn. Even at a smaller length scales clots form regions of platelet-rich and 
fibrin-rich areas, although the mechanism of assembly is unclear (Fig. 2.1). 
2.2.1 Arterial thrombus formation 
Arterial thrombi form at the site of vascular injury to stop the loss of blood out of the 
vessel in a process called hemostasis (Fig. 2.2) To efficiently extend to all reaches of the human 
body, blood flows through a series of arteries, veins, venules, and capillaries called the closed 
circulatory system. Lining this entire network is a layer of endothelial cells that maintain vessel 
patency by providing an inert surface that prevents blood cell adhesion. Endothelial cells also 
actively inhibit clot formation by secreting soluble chemicals (e.g. nitric oxide) that keep 
platelets, the primary blood cell responsible for clot formation, quiescent. At the site of a 
vascular injury, the endothelial cells are denuded or otherwise compromised revealing the 
subendothelial matrix. This matrix promotes clot formation by providing an adhesive surface for  
 
 
Figure 2.1. Model of vascular injury. Human whole blood was perfused over a micropatterned 
spot containing collagen and the procoagulant protein tissue factor at a wall shear rate of 300 s–1. 
Platelets are labeled red and fibrin(ogen) is labeled green. On the left is a top view of a clot and 
on the right a three-dimensional reconstruction. Note the heterogeneous distribution of platelet 




Figure 2.2. Overview of clot formation. Endothelial cells secrete platelet inhibitors that keep 
platelets in a quiescent state. This include prostacyclin (PGI2), ADPases and nitric oxide (NO) 
At the site of an injury the endothelial cells are removed and platelet adhere to and activate on 
the subendothelial matrix that contains various types of collagen and the adhesive protein von 
Willebrand factor (VWF). Once activated platelets secrete soluble agonists such as adenosine 
diphosphate (ADP) and thromboxane A2 (TxA2). These agonists activate new platelets which 
then aggregate with existing platelets in the clot. Platelets can also aggregate in the absence of 
these agonists at high shear stresses. Simultaneously the biochemical reaction pathway called 
coagulation takes place on procoagulant molecules in the subendothelial matrix and on the 
platelet surface. The end product of coagulation is an enzyme called thrombin that acts as a 
platelet agonist and a catalyst for the polymerization of the biopolymer fibrin. 
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platelet adhesion and by exposing procoagulant proteins that initiate a series of biochemical 
reactions called coagulation (Fig 2.3) (34). 
Platelet adhesion occurs either directly through the platelet collagen receptors 
glycoprotein VI (GPVI) and the integrin α2β1 or with the help of another ligand called von 
Willebrand factor (vWF) through glycoprotein Ib (GPIb) (35, 36). Adhesion causes platelets to 
become activated and to secrete platelet-activating chemicals into the surrounding fluid 
activating other platelets.  Following adhesion, platelets can aggregate with each other via the 
ligands fibrin(ogen) or VWF through the integrin αIIbβ3 forming a mass called a platelet plug. 
Coagulation is comprised of the extrinsic and intrinsic pathway. The extrinsic pathway is 
initiated by tissue factor (TF) present on the surface of cells within the vessel wall and also 
circulating in the blood on the surface of white blood cells, cancer cells, and on cell fragments 
called microparticles. TF serves as a co-factor for coagulation factor VII. The TF:VIIa complex 
activates two zymogens IX and X, which then must then make their way from the subendothelial 
surface through the fluid to the surface of an activated platelet to further propagate the cascade. 
Once on the platelet surface Xa binds with factor V to form the prothrombinase complex Va:Xa, 
which converts prothrombin (II) to the critical enzyme thrombin (IIa). Once produced, thrombin 
further activates platelets, acts in a feedback loop to increase the rate of its own production, and 
acts as a catalyst for the polymerization of a fibrous polymer called fibrin. The intrinsic pathway 
is initiated by a myriad of negatively charged proteins (kallikrein, histones), nucleic acids and 
inorganic polymers secreted from cells (polyphosphates) that activate coagulation factor XII. 
Once initiated, the intrinsic pathway proceeds through factor XI to eventually activate factors IX 
and X which results in a bust of thrombin and ultimately in the production of fibrin via the same 






Figure 2.3. Platelet aggregation and coagulation schematics. (left) Platelet adhesion receptors 
and their ligands. Each platelet’s surface bears ≈ 25,000 GPIb receptors that bind to surface-
bound von Willebrand factor (vWF), ≈ 50,000 integrin αΙΙbβ3 receptors that bind to fibrinogen 
and vWF, ≈ 4,000 GPVI receptors, and 1,000–4,000 integrin α2β1 receptors that bind to several 
types of collagen. The integrins must be activated to form strong long-lived bonds. Collagen is a 
major constituent of the subendothelial (SE) matrix; fibrinogen is an abundant plasma protein; 
and vWF is adsorbed to SE collagen, circulates in plasma, and is secreted by endothelial cells 
(ECs). (right) Schematic illustration of coagulation reactions. Most coagulation proteins are 
named using Roman numerals [e.g., factor IX (FIX)] and exist in an inactive (FVIII) and active 
form (FVIIIa). FIIa (also known as thrombin), FVIIa, FIXa, FXa, and FXIa are enzymes; their 
inactive precursors are called zymogens. FVa and FVIIIa are cofactors for the enzymes FXa and 
FIXa, respectively, and must be activated from their precursors FV and FVIII. Tissue factor (TF) 
is a cofactor for FVIIa. The coagulation enzyme-cofactor complexes form on SE and platelet 
surfaces and have enzymatic efficiencies 105–106-fold that of the enzyme alone. The activation 
of a coagulation protein is by proteolysis (i.e., cutting) of the precursor by another enzyme. 
Thrombomodulin (TM) on ECs is a cofactor for thrombin in producing the inhibitor activated 
protein C (APC). Other major inhibitors are antithrombin (AT) and tissue factor pathway 
inhibitor (TFPI). Surface-bound enzyme complexes TF:VIIa, VIIIa:IXa, Va:Xa, and TM:IIa and 
other surface-bound species are shown in boxes. Also shown are cell or chemical activation 
(purple lines), movement in fluid or along a surface (dark blue lines), enzyme action in a forward 
direction (solid gray lines), the feedback action of enzymes (dashed gray lines), binding to or 
unbinding from surface (light blue double-headed arrows), and chemical inhibitors (red circles). 
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2.2.2 Venous thrombus formation 
Less is known about venous thrombus formation than about arterial thrombus formation. 
One major difference lies in the initiation of each. While arterial thrombus formation is initiated 
by endothelial disruption, a frequent mechanism leading to venous thrombosis is stasis in the 
absence of endothelial injury (37). Despite stasis being identified as a cause of venous 
thrombosis, the specific molecular and cellular events that translate depressed venous blood flow 
into thrombogenesis remain unclear. Some have linked inflammation to thrombosis (38, 39). 
Others have implicated leukocytes as a major player where reduced blood flow induces a 
proinflammatory endothelial phenotype initiating the recruitment of innate immune cells, 
particularly neutrophils and monocytes (40). Recruited leukocytes then start fibrin formation via 
blood cell-derived tissue factor, as they support leukocyte accumulation and promote neutrophil 
extracellular traps (NETs) formation. NETs formation, in turn, triggers thrombin production via 
the intrinsic pathway of the coagulation cascade and ultimately fibrin polymerization (41).  
2.2.3 Fibrinogen and fibrin network polymerization 
Fibrinogen is a 45 nm long, 340 kDa, trinodular molecule present in plasma at 
2−4 mg/ml. It is made up of two outer globular domains (D domains) and an inner globular 
domain (E domain) connected by a flexible coiled region (Figure 2.4) (42, 43). Polymerization is 
initiated by cleavage of fibrinopeptides A (FpA) located on the E domain by thrombin. Removal 
of FpA produces a fibrin monomer by exposing binding sites called knobs ‘A’ which are 
complimentary to pockets ‘a’ located on each D-domain. Interactions between the A:a 
complementary binding sites produce aggregates of coupled, half-staggered monomers with the 
knob-hole interactions holding the two monomers together. As more monomers become 
activated, they add longitudinally to the dimer eventually forming large oligomers that are able 
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to laterally aggregate, called protofibrils. Because the process of protofibril formation involves 
two distinct binding steps a third molecule can interfere with the second step of the binding of  
the original two molecules leading to the formation of a branch (43). “Trimolecular junction” 
 
Figure 2.4. Fibrin polymerization schematic. Polymerization is initiated by the cleavage of 
fibrinopeptides A by thrombin producing a fibrin monomer. The fibrin monomers associate via 
knob:pocket interactions to produce a half-staggered protofibril which then laterally aggregate 
with other protofibrils. During polymerization, a third monomer or protofibril may associate with 
a forming fiber resulting in a branch point. Eventually, a single 3D structure is formed with many 
branch points and overlapping fibers. The fibers of this 3D structure are then reinforced by FXIII 
crosslinking. 
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branch points, which have three fibrin branches typically predominate, particularly in highly 
elastic fibrin gels (44, 45).  Eventually a 3D spacefilling branched structure is formed where the 
pore sizes determined by the amount of branching and overlap of the fibers within the network. 
Finally, plasma transglutaminase, factor XIIIa, internally cross-links each fibrin strand by 
covalently connecting the D-domains within a fiber. These crosslinks can transversely connect 
D-domains of fibrin monomers that are already connected via A:a interactions or longitudinally 
connect D-domains of monomers that have no form of direct connection (46-48). This covalent 
crosslinking makes the polymerization process irreversible and stabilizes and strengthens the 
final network. 
2.2.4 Regulation 
Several mechanisms exist to inhibit coagulation preventing uncontrolled thrombus growth. 
Chemical inhibitors [antithrombin III (ATIII), tissue factor pathway inhibitor (TFPI), and 
activated protein C (APC)] present in the plasma act on various species in the network. ATIII is a 
serine protease inhibitor that chemically inactivates thrombin, Xa, and IXa in the fluid phase. 
TFPI is a plasma serine protease that modulates initiations of coagulation by inhibition of both 
Xa and the FVIIa:TF complex. APC proteolytically inactivates VIIIa and Va. 
2.2.5 Fibrinolysis 
After a clot has formed and the wound has healed the process of fibrinolysis dissolves the clot 
and the vessel returns to its original state. During fibrinolysis, the zymogen plasminogen, a 
serine protease in the plasma binds to fibrinogen. Plasminogen is converted to the enzyme 
plasmin by the action of either tissue plasminogen activator (tPA) or urokinase (uPA) that are 
secreted from the endothelial cells, the renal epithelium, or monocytes/macrophages. Once 
active, plasmin cleaves the connecting region between the D- and E- domains of a fibrinogen 
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molecule resulting in a solubilized fibrin degradation product called a D-dimer. Like during 
coagulation, there are a number of chemical inhibitors to this process. Most notable are thrombin 
activated fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 (PAI-1) both of 
which circulate in the plasma. TAFI attenuates fibrin dissolution by decreasing fibrin-binding 
sites for fibrinolytic enzymes. PAI-1 inhibits both tPA and uPA (49) 
2.3 Microfluidic devices for measuring clot formation under flow  
Over the past decade, research has extended beyond identification of the key factors and 
reactions of thrombus formation and into the development of models that combine all three 
elements of Virchow’s triad with additional consideration being given to the effects of shear 
stress, shear rate effects, and transport mechanisms of flowing blood (2, 34, 43, 50-58). Shear 
stress [τ (force/area)] represents the force experienced at the endothelial wall and on the adherent 
blood cells because of the flowing blood. The shear rate [γ (1/time)] represents the velocity 
gradient near the wall and is proportional to the flow rate through the channel. The shear stress is 
related to the shear rate through viscosity [τ = µ × γ] which in the case of blood depends both on 
the fluid velocity and the size of the vessel. The shear rates typically encountered physiologically 
are lowest in veins (20 – 200 s-1), highest in arterioles (50 – 1600 s-1), and high in large arteries 
(300 - 800 s-1). 
 One method of assessing flow-dependent clot formation and/or cell adhesion and 
aggregation is microfluidics. Falling into a subset of flow-based experimental techniques know 
as flow assays, microfluidics offer several advantages over traditional flow-assay techniques. 
Traditional flow-assays have geometries limited to straight channels that result in unidirectional 
laminar flow, require large volumes (10-100 mL), and typically only allow testing of one 
condition (shear rate and substrate) per assay. Consequently, these assays are not able to mimic 
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the fluid dynamics of complex geometries such as bifurcations, stenoses, and convoluted 
interconnected networks that contribute to important biophysical mechanisms, are inadequate 
when only limited sample quantities are available, and have limited throughput. Microfluidics 
address each of these limitations leading to the development of assays that have higher-
throughput and better mimic the vasculature. First microfluidics enables complex geometries. 
One report used microfluidic devices to show that platelets adhere preferentially to low-shear 
regions downstream of stenoses (4). Additionally, microfluidics enables high-throughput and 
simultaneous testing of a range of shear conditions using minimal sample volumes. One such 
device reported the ability to test platelet function on type I collagen coated surfaces over a two 
orders-of-magnitude range of shear rates using only 15 µL of whole blood (59). Additionally, 
microfluidic devices can be combined with micropatterning techniques to define small focal 
patches of prothrombotic substances enabling high-throughput testing of thrombosis and 
hemostasis as a function of injury size and shape. Neeves et al. described a device consisting of a 
100 µm strip of collagen patterned on a glass substrate perpendicular to an array of 13 
microfluidic channels (80 µm × 100 µm) (60). This collagen ‘injury’ mimics the focal nature of 
animal models like the laser injury model, eliminated upstream issues regarding upstream 
activation of platelets, and enables real-time image quantification. These advantages make 
microfluidics ideal for the high-throughput study of flow-formed thrombi formation. 
2.4 Flow-formed clot structures 
One particularly important aspect of flow-based systems is the accumulation of clot 
components at the injury site that effect the growth, arrest, dissolution, and overall strength of a 
clot. Scanning electron micrographs of focused ion beam milled clots show both increased solid 
fractions (> 0.02 v/v) relative to statically formed clots and pore structures in both platelet-rich 
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and fibrin-rich regions of clots formed under flow in vitro that contain at least two length scales 
(Fig. 2.5). One length scale is defined by the blood cells, which can have diameters ranging from 
1−25 µm and volume fractions ranging from 0.01−0.9. The space between cells can range from 
just few nanometers to hundreds of micrometers. The second length scale is defined by the fibrin 
matrix, which typically has diameters of 10-1000 nm. The fibrin matrix is mostly water by  
volume (>90%) and is extremely compressible and extensible. The space between fibers in the 
matrix can range from 1 nm to 100 µm. Taken together, these structures yield a mixed 
poroelastic medium where a set of roughly spherical objects (cells) is separated by a fibrous 
medium.  
This pore structure affects a number of physical properties of a clot including the rate of 
solute and fluid transport and the mechanical strength of the clot. Solute movement in the clot is 
limited based on the relative diameters of the solutes and the pores and can result in the physical 
inhibition of coagulation factors within a growing or formed clot (21, 61-65). For instance, a 
 
 
Figure 2.5. Scanning electron micrographs of focused ion beam milled of blood clots formed in 
vitro on collagen-tissue factor substrates at 100 s–1. Left: Interstitial pores in a fibrin-rich region 
of the clot. A red blood cell (RBC) drapes over the top of the clot. Right: Interstitial pores in a 
platelet-rich region of the clot. 
 20 
two-fold increase in solid fraction within in vivo formed clots was shown to result smaller pores 
and in up to a 16-fold reduction in the rate of solute transport (58, 66). Interstitial flows in the 
pores exist owing to the pressure gradient created by flowing blood along the periphery of a clot 
and by the pressure gradient that exists between the blood vessels and the lymphatic vessels. 
These interstitial flows are typically small (< 1 cm s−1), but are important for the exchange of 
coagulation factors, the delivery and retention of drugs, and the stability of the clot (34, 58, 67). 
Differences in introduction and removal rates due to flow conditions, pore structure, and platelet 
and protein binding determine the mass accumulation or loss at the injury site and may also serve 
as a physical mechanism for clot arrest.  For small clots, flow-mediated dilution of reacting 
species is much more potent mechanism of clot arrest than chemical inhibition (50). In larger 
clots, adhesion of platelets to the subendothelium serves as a transport barrier preventing 
coagulation factors in the fluid from reaching surface-bound enzymes (Fig. 2.6). For instance, in 
vitro experiments have shown that the transport caused by clot solids can result in a 400-fold 
reduction of activation of X to Xa (68). After a clot has formed pressure-driven permeation is the 
main mode of transport within the clot, allowing for kinetically relevant thrombolysis. Without 
pressure driven permeation a fibrin clot can require over 1000 min to achieve 50% lysis with 
tPA; however, pressure-driven permeation was able to achieve 50% lysis in less than 20 min 
(20). Finally, the accumulation of components caused by transport determines, in part, the 
mechanical strength of a clot. Increased solid fractions within a clot generally leads to an 
increase in material strength and determines the susceptibility of the clot to embolism (12, 69). In 
particular, the concentration of fibrin in a clot is important as small changes in fiber volume 
fraction result in large changes in elastic modulus of fibrous materials. Overall, the relationship 
between flow-dynamics, pore structure and component accumulation, and physical properties 
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plays an integral role in the life cycle of a clot. 
Despite their importance, there is a paucity of data on the physical properties of clots 
formed at solid fractions reflective of those formed under flow. The data that does exist has been 
collected at fibrin and platelet concentrations that are orders-of-magnitude less than what has 
been reported in clots formed in vivo (70, 71). The focus of this thesis is on the physical 
properties of clots formed with high platelet and fibrin concentrations that result from the 
advection of solids in clots formed under flow. Here, I provide an overview of the physical 
properties of permeability, hindered diffusivity, and viscoelasticity that determine the rate of 
interstitial flow, solute movement, and mechanical strength of thrombi, respectively. 
2.5 Overview of porous media 
This description of porous media is based on the description given in Chapter 8 of 
Truskey et al. (72). Porous media are solid materials with internal pore structures. The pore 
structure of a material varies significantly among different media and can be random or have a 
 
Figure 2.6. The solid components of the clot (platelets and fibrin) serve as a physical mechanism 
to inhibit clot growth. (A) Immediately after injury coagulation factors (X, IX) in the plasma are 
able to contact coagulation factors on the injury surface (TF:VIIa) where they become activated 
and promote clot growth. (B) After clot formation platelets and fibrin physically inhibit the 
transport of coagulation factor between the plasma and the injury surface. Adapted from 
Hancock and Nemerson (68). 
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well-defined structure. Random structures (Fig. 2.7 A & B) are often found in vivo, can have a 
range of pore size and spacing, and the porosity can vary throughout the material. Regular 
structures (Fig. 2.7 D & E) are often found in industrially fabricated materials such as women 
fabrics or processes such as heat exchangers and can have well defined pore sizing, spacing, and 
porosity.  
Both random and regular structures can be fibrous, granular, or a combination of both. Fibrous 
structures (Fig. 2.7 A & D), such as hydrogels and woven fabrics, consist of many long thin 
solids and can have much of their overall volume occupied by the pore space. Granular structures 
 
Figure 2.7. Various types of propos media. (A) Random fibrous media is comprised of an 
assortment of fibers with an isotropic orientation. Many biological gels including fibrin can be 
described as random fibrous media (B) Random granular media is comprised of granules of 
various sizes and spacings. (C) Mixed porous media has often has two length scales, one 
described by the fibers that inhabit the pores of the granules. Thrombi can be considered mixed 
media. (D) Regular fibrous media. (E) Regular porous media. (F) Pores can be either passing, 
isolated, or nonpassing. Adapted from Truskey et al. (72). 
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(Fig. 2.7 B & E), such as rock or sand, consist of solid particles and the pore space in between. 
Biological structures tend to be heterogeneous and can contain a mixture of both granular and 
fibrous structures simultaneously (Fig 2.7 C). In thrombi the solid structures are made primarily 
of platelets and fibrin but can also include red blood cells, white blood cells, and proteins. The 
cellular fraction is best described as granular and the fibrin as fibrous. The internal pores are 
filled with plasma that can contain free cells, or dissolved proteins, salts, and sugars. 
Porous media are often characterized by their total porosity, ε, defined as: 
 (2.1) 
where Vvoid is the void volume and Vtotal is the total volume of the of the media. Though porosity 
provides a measure of the total void space of porous media, it does not account for the 
connectivity of pores or for which pores are available for transport. Pores can be isolated, 
nonpassing, or passing (Fig. 2.7 F). Isolated pores are not accessible to external solvents or 
solutes and do not contribute to the available pore space for transport. Nonpassing pores are 
accessible only at one external site. Solvents and solutes can travel in and out of nonpassable 
pores, but are unable to pass through the media. Passing pores either have two external access 
points or connect to other pores providing multiple external access points and enable solvents 
and solutes to pass through the media. The path length between the two endpoints of a passing 
pore is described by it tortuosity, T: 
 (2.2) 
where Lpath is the path length of the pore and Lstraight is the straight-line distance between the two 
ends of the pore. Taken together, porosity, tortuosity, as well as pore size can have a significant 








2.6 Transport in porous media 
Fluid and solute transport in porous media is of great importance in a wide range of 
applications including, but not limited to, transport of underground water and pollutants, 
hydrocarbon recovery, filter analysis, and thrombus formation. Permeability is a measure of the 
ability of fluids to pass through the pore space of a structure. It is among the most important 
properties that characterize a porous media and provides information of both pore size and of 
fluid and solute transport within a porous medium. 
2.6.1 Permeability 
 Two methods exist to describe fluid flow in porous media, pore-level and 
continuum. The pore-level method requires solving the governing equations for fluid flow in the 
individual pores. The continuum method assumes the flow in individual pores can be represented 
by an averaged quantity at larger length scales and treats the porous media as a uniform material. 
For the continuum approach to be valid several length scale characteristics must hold true. First, 
the average pore size, dpore, must be much smaller than the characteristic length over which 
fluctuations in the porosity vary, LREV. The volume with dimensions LREV is known as the 
representative elementary volume (REV). This volume is assumed to be representative of the 
entire media. If the length of the sample over which fluid flows is much larger than LREV the 
details of the porous structure are ignored and any physical quantity in the material is defined as 
the volume average of the same quantity in a pure medium. 
The equation for momentum balance in porous media is the phenomenologically derived 
Darcy’s law (73): 




where v is the average velocity of the fluid, µ is the fluid viscosity, P is the pressure and k is a 
second order tensor and a material property called the permeability of the material that depends 
upon the microscopic structure of the material. In this work thrombi are assumed to be both 
isotropic and homogeneous on the length scales tested, reducing permeability to a scalar. 
Though initially empirically derived, Darcy’s law has been theoretically derived from the 
Navier-Stokes equations using volume averaging techniques and assuming Stokes flow (74, 75). 
As such, Darcy’s law is only valid for Newtonian flows with low Reynolds numbers (NRe < 1). 
Flows within thrombi can be considered to be Newtonian due to blood plasma being comprised 
largely of water. The small characteristic lengths associated with the components of thrombi 
dictate that the Reynolds number is sufficiently small (NRe << 1) at physiological relevant flow 
rates. Thus the assumptions used in deriving Darcy’s law are valid in thrombi 
Conceptually, Darcy’s law can be derived assuming the porous medium is comprised of a 
well-define geometry—a regular array of nA straight cylinder pores per unit cross-section each 
with a pore diameter, dpore (Fig. 2.8). Solving the Navier-Stokes equations results in the 








where qpore is the volumetric flow rate in each pore, dp/L is the pressure drop across the length of 
the pore, and µ is the viscosity of the fluid. The total flow across the entire porous medium, Q, is 
equal to the sum of the flow across each cylinder: 
Q = AnAqpore  (2.5) 
where A is the cross-sectional area of the porous medium. The velocity in the entire porous 

















 (2.7)  
From this example it is easy to see that permeability, k, is a material property directly controlled 
by the pore size within the material (dpore) and porosity (nA). Through the permeability is 
determined by the pore geometry of the porous medium, the average velocity through the 
medium, vDarcy, represents the average fluid velocity through the medium and neglects to 
specifically account for the microscopic geometry. Because permeability is determined by the 
solid fraction and the pore geometry of the medium it can be used to predict other pore-size 
 
Figure 2.8. The permeability of a regular porous medium with a well-defined geometry can be 
derived from the Navier-Stokes equations. The velocity through the medium, vDarcy, is dependent 
on the velocity in the pores, vpore, which is a function of pore geometry and the pressure drop 
across the porous medium. 
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dependent phenomena such a solute diffusion or mechanical properties both of which are 
controlled at least in part by network size. 
2.6.2 Diffusion in porous media 
The governing equations of diffusion in porous media are the same as those in free solutions. 
Fick’s law still governs diffusion, however, diffusivity in porous media can be limited both by 
steric and hydrodynamic effects. Steric effects result when the diameter of a solute particle is 
larger than the diameter of a pore and the pore becomes impassable to the solute (Fig. 2.9 A). 
Hydrodynamic effects occur due to increased particle drag caused by the particle passing near a 
pore wall (Fig. 2.9 B). At low Reynolds numbers the disturbance produced by a moving particle 
extends well beyond the boundary of the particle to the pore wall. Thus the pore wall can have a 
significant effect on diffusion. These steric and hydrodynamic effects are collectively known as 
hindered diffusivity and depend on many factors including solute diameter, pore diameter, and 
tortuosity. Accounting for these effects, diffusion coefficients in porous media are expressed as 
an effective diffusion coefficients, Deff,; 
 (2.8) 
where D0 is the diffusion coefficient of the solute in free media, F is a function accounting for 
increased drag on the solute due to near wall effects, and S is a function accounting for steric 
effects and tortuosity. Because both permeability and hindered diffusivity are functions of pore 
size and tortuosity, effective diffusion coefficients are often expressed in terms of the 
permeability of the porous media. Therefore, we expect that measurements of permeability will 




2.7 Mechanical properties of biological networks 
Fibrin, one of the main components of a thrombus, is a fibrous network responsible for 
controlling a clot’s mechanical properties; determining if the thrombus will be able to withstand 
the stresses imparted on it by the flowing blood, if it will deform reversibly or irreversiblly, or 
embolize. For instance, “acute” or newly formed thrombi with lower relative stiffness are more 
susceptible to embolism than “mature” thrombi with higher stiffness (76, 77). Categorizing the 
type of network (flexible, semi-flexible, or rigid) and the linear and non-linear elastic properties 
of the thrombus is important to determining mechanical integrity of a thrombus. Below is a 
discussion of network type, mechanical regimes, and a brief introduction of the methods used to 
describe each. 
 
Figure 2.9. Hindered solute transport in pores. (A) Steric hindrance occurs when the solid 
component of the porous media physically blocks the solute particle. If the diameter of the pore 
is smaller than the particle diameter the particle will be sterically blocked. (B) Hydrodynamic 
hindrance occurs when viscous drag from the nearby pore cause the solute particle to move more 
slowly than in free media. Smaller pores result in increased effective drag relative to larger 
pores, even if the solute particle diameter is less than the pore diameter. 
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2.7.1 Network Categorization 
Biological networks are a subset of a larger category of polymer networks, the mechanics of 
which can be sorted into one of three regimes, flexible, semi-flexible, or rigid, based on the ratio 
of the length scales, persistence length, lp, and contour length, Lc, of the fibers within the network 
(Fig. 2.10) (78-80). Persistence length is the typical length scale for the decay of tangent-tangent 
correlations of a polymer chain (81). Contour length is the total length of the polymer chain 
between crosslinks. When lp << Lc the polymer chain is considered to be flexible. Flexible 
polymer mechanics are based on changes in the confirmation of the polymer chain and describe 
the elasticity of rubber-like polymers such as vulcanized natural rubber (82). At sufficiently large 
strains the chains of a flexible polymer maintain sufficient “slack” to form loops and maintain 
thermal fluctuations resulting in linear elastic behavior over wide range of strains. The elasticity 
of most biopolymer networks, including fibrin, is poorly described by flexible polymer 
mechanics. Semi-flexible thermal polymer elasticity is derived from the thermal fluctuations of 
the filaments between crosslinks and resist strain due to a decrease in entropic confirmations 
(83). When lc is comparable to Lc the polymer chain is said to be semi-flexible. Semi-flexible 
filaments are not flexible enough to forms loops within the polymer chain, yet are sufficiently 
flexible to undergo thermal bending fluctuations. Strains of only a few percent are sufficient to 
remove the “slack” from the network chains resulting in nonlinear behavior at moderate strains. 
Finally, when lp >> Lc the filaments are considered to be rigid and athermal. The filaments 
between crosslinks of athermal elastic-rod networks are sufficiently rigid to not undergo thermal 
fluctuations in the unstrained state. The elasticity of this type of network is derived from 
enthlapic bending and/or stretching of the filaments when strained and nonlinear behavior results 
from network properties (84). 
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2.7.2 Viscoelasticity and small strain dynamic mechanical analysis  
This derivation of the Maxwell model of viscoelasticity and analysis through harmonic 
motion is presented in Chapter 8 of Rodriguez et al. (82). Viscoelasticity is the tendency of a 
material to exhibit both viscous and elastic behavior in response to deformation. Viscosity is a 
measure of the energy dissipated by a fluid in motion under the action of an applied force. 
Elasticity is a measure of energy stored by a material under the action of an applied force. When 
the amplitude of the strain is small a linear relationship between stress and strain is observed and 
the elasticity is considered to be linear. The strains at which linear behavior is observed and 
strain is considered small is material dependent and typically determined experimentally. 
 
Figure 2.10. Fiber type determines the behavior of the network. Polymer networks are described 
as flexible if the persistence length, lp, of the fiber is much less than it contour length, Lc,. Even 
at large strains, thermal fluctuations still persist within the chain. If the persistence length, lp, of 
the fiber is roughly equal its contour length, Lc, the network is described as semi-flexible. Stains 
of only a few percent are sufficient to eliminate the thermal fluctuations of the fiber. If the 
persistence length, lp, of the fiber is much less than its contour length, Lc, the network is 
described as rigid and the filaments do not have significant thermal fluctuations. Increased strain 
results in the stretching of the fiber. 
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Viscoelasticity is most easily illustrated by Maxwell’s spring and dashpot model. A 
Hookean spring assumes: 
 (2.9) 
where σS is the stress due to elongation of the spring, E is the Hooke’s law constant or elastic 
modulus of the material, and γE is the elongation of the spring. The Newtonian viscous 
relationship is given by: 
  (2.10) 
 where σD is is the viscous stress of the dashpot, η is the fluid viscosity, and dγD/dt is the rate of 
elongation (dashpot movement) over time. Assuming the total strain is equal to the sum of 
individual strains: 
 (2.11) 
and that the stress is constant across the element: 
 (2.12) 
allows for a combined expression (combination of Eqns. 2.10-2.12) of stress and strain as a 
function of time, and the physical constants E and η: 
 (2.13) 
Eqn. 2.13 is the basis for the most popular technique used to quantify the viscoelasticity of a 
material known as dynamic mechanical analysis (DMA). DMA allows for the characterization of 
the viscoelastic properties of a material by imposing a continuous sinusoidal force on a material.  
The stress-strain relationship of a Maxwell element (Eqn. 2.13) in complex notation is given by: 
 (2.14) 
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where γ* is the complex strain and σ* is the complex stress. Sinusoidal forces acting on a 
Maxwell element result in a strain with the same frequency as the force input, but out of phase. 
Therefore, substituting the derivative of a complex strain function with respect to time (the real 
part of which is the actual strain): 
 (2.15) 
and its derivative: 
 (2.16) 
where γm is the maximum strain, t is time, and ω is frequency into Eq. 2.14, results in 
measureable stresses being a function of the elastic modulus, E, the max elongation, γm, 
frequency and time.  
 (2.17) 
Solving the linear differential equation (Eq. 2.17) yields the following result for complex stress 
and strain: 
 (2.18) 
where θ is the ratio of viscosiy to elastic modulus, η/E. The real term in Eq. 2.18 is known as the 
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Substitution of Eq. 2.20 into Eq. 2.19 yields: 
 (2.21)
 
The actual stress, σ, is the real part of σ* which depends on E and γ* but leads by a phase angle 
δ. The max stress occurs at ωt+δ = 0, giving 
 (2.22) 
which when substituted into Eqn. 2.21 yields: 
 (2.23) 
Thus, measuring the stress within a sample while imposing an oscillatory strain allows for 
identification of storage, E’, and loss moduli, E”, as a function of frequency, ω, max stress σm, 
and time, t. 
2.7.3 Nonlinear elasticity 
In addition to small deformation linear elastic properties, many biopolymer networks, 
including fibrin, exhibit nonlinear elastic properties that are currently not well understood. For 
instance, fibrin gels strain harden at moderate strains and generate negative normal stresses in 
response to shear stress. Stain hardening occurs in both fibrin gels and in individual fibrin fibers. 
The onset of hardening for an individual fibrin fiber begins at strains above 100%, yet strain 
hardening in fibrin gels begins around strains of 10% (81, 85). Further, strain hardening at low 
strains (below 75%) is attenuated for fibrin gels formed at high fibrin concentrations and in the 
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strained in a simple geometry. More generically, fibrin gels “pull” or “contract” in the normal 
direction in response to stress in the shear direction. The magnitude of the stress generated is 
dependent upon the nature of the fiber network and upon the strain. Both of these nonlinear 
behaviors are not described by rubber theory. In particular, it is unclear how these properties are 
affected by strain and fibrin concentration and if these nonlinearities are caused by the mechanics 
of the network, by the mechanics of the individual fibrin fiber, or by a combination of both. 
2.8 Summary 
Taken together, the complex fluid dynamics of the circulatory system significantly effects 
thrombus formation. Flow, in part, is responsible for determining the rate of accumulation of clot 
components and plays a role in receptor-ligand dynamics. These effects result in thrombi with 
complex porous structures which, in turn, affect the rate of fluid and solute transport in the 
thrombi. Thus, fluid dynamics and clot structure exchange in a feedback loop that determines the 
final structure of the clot. Finally, the final structure of the clot determines the mechanical 
properties of a clot and ultimately determines if the clot will remain a physically stable 
component of the hemostatic process, deform to result in excess bleeding, or embolize and 




THE HYDRAULIC PERMEABILITY OF BLOOD CLOTS AS A FUNCTION OF 
FIBRIN AND PLATELET DENSITY 
Modified from a paper published in Biophysical Journal* 
A.R. Wufsus†‡, N.E. Macera† and K. B. Neeves†§ 
3.1 Abstract 
Interstitial fluid flow and solute diffusion within blood clots are biophysical mechanisms 
that regulate clot growth and dissolution. Assuming that a clot can be modeled as a porous 
medium, the physical property that dictates interstitial fluid flow and solute diffusion are the 
hydraulic permeability and the hindered diffusivity. The objective of this study was to bound the 
possible values of these physical properties in clots formed in vivo and present relationships that 
can be used to estimate clot permeability and hindered diffusivity as a function of composition. 
A series of clots with known densities of fibrin and platelets, the two major components of a clot, 
were formed under static conditions. The permeability was calculated by measuring the 
interstitial fluid velocity through the clots at a constant pressure gradient. Hindered diffusivity 
was measured with a diaphragm diffusion cell and by fluorescence recovery after 
photobleaching. Fibrin gels formed with a fiber volume fraction of 0.02 – 0.54 had 
permeabilities of 1.2 × 10-1 – 1.5 × 10-4 µm2. Platelet rich clots with a platelet volume fraction of 
0.01 – 0.61 and a fibrin volume fraction of 0.03 had permeabilities over a range of 
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1.1 × 10−2 −1.5 × 10-5 µm2. Fibrin gels formed with a fiber volume fraction of 0.36 reduced the 
diffusion coefficients of 12, 29, and 54 nm solutes by 60%, 66% and 85%, respectively. Platelet 
rich clots with a platelet volume fraction 0.61 reduced the diffusion coefficient of a 12 nm solute 
93%. The permeability of fibrin gels and of clots with platelet volume fraction of < 0.2 were 
modeled as an array of disordered cylinders with uniform diameters. Clots with a platelet volume 
fraction of > 0.2 were modeled as a Brinkman medium of coarse solids (platelets) embedded in a 
mesh of fine fibers (fibrin). Hindered diffusivity of fibrin gels and platelet rich clots was 
predicted using permeability measurements and the effective medium model. Our data suggests 
that the permeability of clots formed in vivo can vary by up to five orders-of-magnitude, with 
pore sizes ranging from 4−350 nm that significantly restrict solute diffusion. These findings have 
important implications for the transport of coagulation zymogens/enzymes in the interstitial 
spaces during clot formation, as well as the design of fibrinolytic drug delivery strategies. 
3.2 Introduction 
Interstitial fluid flow through the extracellular space is an important phenomenon in the 
homeostasis, development, and pathology of tissues (67). Interstitial flows have been used to 
distribute drugs and drug delivery systems by either exploiting endogenous flows (87) or 
inducing flow by local infusion into a targeted tissue (88, 89). Blood clots are a tissue where 
interstitial flows exist owing to the pressure gradient created by flowing blood along the 
periphery of a clot. There is growing evidence that interstitial fluid and solute transport plays an 
important role in the growth, arrest, and dissolution of blood clots (34, 90). However, there are 
few measurements of the constitutive properties in clots that regulate interstitial transport. One of 
those properties is the permeability.  
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The permeability of a porous medium can be calculated from Darcy’s law: 
v = − k
µ
∇P
  (3.1) 
where v is the interstitial fluid velocity, k is the permeability, µ is the viscosity of the percolating 
fluid, and P is the pressure. The permeability is a function of the volume fraction of solids, pore 
size, and fiber or cell/cell aggregate size. A blood clot, like most tissues, is a material that has 
both fibrous and granular structures. We define fibrous structures as those defined by proteins 
and carbohydrates in the extracellular space and granular structures as those defined by cells. 
Fibrin fibers that form between and around platelets give the clot a fibrous structure. Platelets 
and platelet aggregates give the clot a granular structure. The relative density of these two 
components—fibrin and platelets—dictates the interstitial fluid transport. The diffusivity of a 
solute across a clot can be calculated from Fick’s law: 
j = −D∇c  (3.2) 
where j is the flux, c is the concentration and D is the diffusivity. The diffusivity across the 
membrane is a function of the solute size and the volume fraction of the solids, pore size, and 
fiber or cell/cell aggregate size. The objective of this study is to measure and model the hydraulic 
permeability and hindered diffusivity of clots as a function of platelet and fibrin density. 
The hydraulic permeability of pure fibrin gels has been extensively measured dating back 
to Ferry and colleagues seminal studies in the 1970s (14, 15). To date, most reports of fibrin gel 
permeability have been measured at or near plasma fibrinogen concentrations (~ 3 mg/mL) (19). 
These permeability measurements are typically used to determine how biochemical conditions 
affect fibrin polymerization. For example, for a given fibrinogen concentration, fibrin gels 
formed at higher thrombin concentrations consist of densely packed thin fibers compared to gels 
formed at low thrombin concentrations (19). Permeability has also been used as a measure of 
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how a drug or certain disorders affect fibrin polymerization. Consumption of low doses of 
acetylsalicylic acid results in a 44% increase in fibrin permeability (18). Fibrin clots made from 
the plasma of individuals following ischemic stroke have lower permeability than healthy 
controls (16). Similarly, the hindered solute diffusion in hydrogels and other porous mediums 
has been extensively studied (61, 91). Most of these reports have focused on the effects of 
component size or charge in gels with very low solid fractions (<0.05) (62, 92-95). A major 
conclusion of these works was the degree of hindered diffusivity is directly related to the 
permeability of a medium (62). Permeability provides an estimate of the screening length or 
diameter of a porous medium; therefore, the degree of hindered diffusion can be predicted as a 
function of solute size and permeability of the medium.     
There are few direct measurements of the permeability or hindered diffusivity of clots 
with significant cellular volume fractions. The volume fraction of platelets in clots formed from 
platelet rich plasma is ~0.005, too small to significantly influence the permeability or diffusion. 
Yet, the histology of clots retrieved from humans with atrial fibrillation and stroke suggest that 
platelets make up 20-80% of the solid volume (96, 97). Furthermore, the density of fibrin is 
likely much higher in clots than in gels formed at plasma concentration of fibrinogen. A recent 
electron microscopy study of aspirated clots from myocardial infarction patients found an 
average fibrin solids volume fraction of 56% (31).  
In this study we measured how the volume fraction of fibrin and platelets affects fluid 
and solute transport within the interstitial spaces of clots. The focus here is on platelet rich clots 
that are characteristic of the initial stages of hemostatic and thrombotic clots. Our approach was 
to induce clotting with thrombin in suspension with known fibrin and platelet densities, and then 
measure the permeation of a buffer solution through the clots at defined pressure gradients and 
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the diffusion of dextran solutes through the clots in the absence of a pressure gradient. Clots 
were treated as porous media where the average interstitial fluid velocity at the macroscopic 
scale was governed by Darcy’s law. We measured the permeability and hindered diffusivity of 
fibrin gels with a fiber volume fraction of 0.02-0.54 and platelet rich clots (PRC) with a platelet 
volume fraction of 0.01-0.61. Measured permeability values were compared to models of 
fibrous, granular and mixed porous media to delineate the relative contributions of each 
component to the overall hydrodynamic resistance. Measured hindered diffusion coefficients 
were compared to values predicted by a hindered diffusivity model that accounts for both steric 
hydrodynamic hindrances (92). These data bound the range of clot permeability and hindered 
diffusivity and can be used for predicting clot growth and dissolution. 
3.3 Materials and methods 
Human fibrinogen (free of plasminogen, von Willebrand factor and fibronectin) in 
20 mM sodium citrate, human α-thrombin and bovine α-thrombin were purchased from Enzyme 
Research Laboratories (South Bend, IN). Centrifuge filtration units with a 50 kDa molecular 
weight cut off were purchased from Millipore Corporation (Billerica, MA). Citrated bovine 
whole blood was purchased from Hemostat Laboratories (Dixon, CA). Trizma buffer, calcium 
chloride, sodium chloride and hexamethlydisilazane (HMDS) were purchased from 
Sigma-Aldrich (St. Louis, MO). Tris buffered saline (TBS; 50 mM Tris, 100 mM NaCl) was 
made in house at pH 7.4. AlexaFluor 488 labeling kit, DiOC6, Oregon Green 488 (70 kDa), 
tetramethylrhodamine labeled dextrans (500 kDa and 2,000 kDa), and fluorescein isothiocyanate 
(FITC) (70, 500, and 2,000 kDa) were purchased from Molecular Probes (Grand Island, NY). 
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3.3.1 Fibrinogen Solution 
Fibrinogen stock solutions (14.2 mg/mL) in sodium citrate were concentrated to 
130−160 mg/mL by centrifuge filtration. Two milliliters of the stock solution were centrifuged at 
2200g for 10 h. After centrifugation the retentate was removed from the device and diluted for 
permeability measurements. A modified Clauss assay was performed to determine the fibrinogen 
concentration of the retentate (98). Briefly, 10 nM thrombin and 2.5 mM CaCl2 was added to the 
diluted (100:1 in TBS) retentate fibrinogen solution into a well of a 96 well plate (200 µL final 
volume). After 20 min, the absorbance was measured in a plate reader (Victor X, PerkinElmer) 
and the concentration was calculated by comparing the absorbance to a standard curve.  
3.3.2 Fibrin Gel Preparation 
Permeation chambers were created by removing the top of the barrel of 3 mL plastic 
syringes (BD, Cat #309585) and sealing the adaptor of the syringe with a polydimethlysiloxane 
(PDMS) cork. Prior to forming a fibrin gel, 1.1 mL of a 3 mg/mL fibrinogen solution was 
incubated in the permeation chamber for 1 h and then rinsed with deionized water and dried with 
an airbrush. The adsorbed fibrinogen was necessary to provide an adhesive surface for the fibrin 
gels. Next, the fibrinogen solution used for gelation was added to the permeation chamber and 
1M CaCl2 was added to a final concentration of 2.5 mM CaCl2. Finally, 200 nM human 
α-thrombin was added and quickly mixed with a Pasteur pipette to yield a final concentration of 
10 nM thrombin. The chamber was then sealed with parafilm and allowed to gel for 24 hr. Fibrin 
gels were prepared for fluorescence recovery after photobleaching (FRAP) measurements by 
forming fibrin gels (20 µL) in dextran/buffer solutions (40 nM dextran) between a glass slide and 
a coverslip. Gels were allowed to form for 24 hours prior to FRAP measurements. 
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3.3.3 Platelet Rich Clot Preparation 
Platelets were isolated from citrated bovine whole blood in a three-step process: (1) 
Whole blood was centrifuged at 40g for 2 h resulting in an erythrocyte rich bottom fraction and a 
platelet rich plasma (PRP) top fraction. (2) The PRP was pipetted off the top and then 
centrifuged at 2200g for 20 minutes. This step resulted in a platelet plug at the bottom of the 
centrifuge tube and platelet poor plasma (PPP) in the supernatant. (3) The platelet plug was 
resuspended in the PPP to the desired cell count. The PPP from (2) was added to the erythrocyte 
rich bottom fraction from (1), and the two-step centrifugation process was repeated again to 
extract the maximum number of platelets. From 1 L of whole blood, we recovered 2-4 mL of 
packed platelets. Packed platelets were diluted in plasma and the cell density was measured 
using a hemocytometer (DHC-N01, Neubauer Incyto, Chonan, South Korea). Once diluted to the 
desired platelet density, suspensions were prepared for permeation and diffusivity measurements. 
For permeability measurements, 500 µL of the resuspended platelets were transferred to the 
3 mL permeation chambers and recalcified to 20 mM CaCl2. Clot formation was induced with 
10 nM bovine α-thrombin. Clots were allowed to form for 24 h to ensure complete conversion of 
fibrinogen to fibrin. For diffusivity measurements, clots were allowed to form on stainless steel 
mesh supports with a mesh size of 200 µm and allowed to form in a humid chamber for 24 h. 
3.3.4 Hydraulic permeability measurements 
After removal of the PDMS plug and the parafilm seal, a reservoir containing TBS was 
connected to the top of the permeation chamber (Fig. A-2). Small diameter silastic tubing 
(0.76 mm ID, Dow Corning, Midland, MI) was connected to the bottom of the chamber via a 
blunt 16 gauge needle. The volumetric flow rate of buffer through the fibrin gel or platelet rich 
clot was calculated by tracking the velocity of the air-buffer interface in the tubing. The 
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volumetric flow rate of the TBS was measured at 3−5 pressure gradients for 5 min. The large 
volume of the TBS reservoir ensured that the pressure gradient was constant over the course of 
the measurements. Measurements at different pressure gradients were taken in random order. We 
used a pressure gradient that was adequate to provide a measurable flow rate (1-10 µL/min) but 
did not posses enough force to rupture the gel. The flow through the clot was visualized by 
adding a food dye to the permeation buffer in a 1000:1 dilution. Ruptures or detachment from the 
wall were identified by fingers of dye protruding into the gel/clot. 
3.3.5 Scanning electron microscope measurements of fiber diameter 
Gel samples were prepared for scanning electron microscopy (SEM) by forming gels 
(3−156 mg/mL, 2.5 mM CaCl2, 105 mM NaCl, 100 nM thrombin) in a Slide-A-Lyzer mini 
dialysis devices (ThermoScientific, Cat. No. 69560, Rockford, Il). After gelation, the clots were 
fixed in 2.5% glutaradehyde for 30 min. Next, the dialysis device was immersed in the following 
series of solutions for 10 min each to dehydrate the samples: deionized water in triplicate, 50%, 
70%, 80%, 90%, 100%, 100% ethanol in DI water, 33%, 67%, 100%, 100% HMDS in ethanol. 
After the final HMDS treatment the clot was removed from the dialysis device and air dried 
before being sputtered with ~10 nm of gold. SEM images were taken at an accelerating voltage 
of 1.5 kV and 6 mm working distance. ImageJ software was used to manually measure the ~100 
fiber diameters for each condition.  
3.3.6 Confocal microscopy of fibrin gels and platelet-fibrin thrombi 
Fibrin gels and PRC for confocal microscopy were prepared exactly as described above, 
except rather than forming the samples in a permeation chamber, the samples were formed 
between glass slide and glass coverslip. For fibrin gels, a fluorescently labeled fibrinogen 
(AlexaFluor 555) was added to each solution at a molar ratio of 1000:1 unlabeled:labeled 
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fibrinogen. For PRC, platelets were labeled with DiOC6 (10 µM mM) and fluorescently labeled 
fibrinogen was added at a molar ratio of 250:1 unlabeled:labeled fibrinogen. Images were 
captured on a laser scanning confocal microscope (Olympus Fluoview FV10i) using a 60X 
objective (NA = 1.2) and excitation/emission wavelengths of 556/573 nm and 495/521 nm for 
the AlexaFluor555 and DiOC6, respectively. Grayscale images were made binary in ImageJ 
software by subtracting the background using the Sternberg rolling ball method with a rolling 
ball radius that was at least 5 times larger than the largest group of platelets (~100 µm for higher 
platelet concentrations, ~10 µm for the 50x and below).  After background subtraction a 
threshold value of 5 was applied to all images and the platelet volume fraction was calculated 
from binary images. The average area and diameter of platelet aggregates was also calculated 
from the binary images. Each step in the image analysis procedure is depicted in Fig. A-3.  
3.3.7 Hindered diffusivity measurements 
Fluorescence recovery after photobleaching (FRAP) is often used to measure diffusion 
coefficients in biological systems such as lipid bilayers or in intracellular compartments. The 
solute to be measured is labeled with a fluorophore that is known to easily photobleach with a 
suitable laser intensity. The diffusion of fluorescent molecules into the bleached region is 
measured over time and the transient recovery of fluorescence is used to calculate a diffusion 
coefficient. Here, we use FRAP to measure the diffusion of FITC-labeled dextrans of 12, 29, and 
54 nm in diameter in fibrin gels. Diffusion coefficients were calculated from the transient 
recovery profiles using the Matlab code described by Jönsonn and colleagues (99). Owing to 
light scattering by platelets we could not use FRAP for platelet rich clots, and instead used a 
custom diaphragm diffusion cell as previously described (100). Briefly, TBS solution containing 
C/C0 = 1 and C/C0 = 0 solutions of dextran were pipetted into well-mixed reservoirs on opposite 
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sides of the formed clot. Dextran concentrations in each reservoir was measured over 5 days in a 
plate reader by removing a small sample from each reservoir. Samples were returned to their 
respective reservoirs after each measurement to maintain a constant volume. Effective diffusion 
coefficients in each clot were determined by using the MatLab function robustfit to fit the data to 
the function, which was determined by a combination of Fick’s law and a total mass balance: 
Clow −Cup
Clow,0 −Cup,0
= e−βDt  (3.3) 
where Clow and Cup are the dextran concentrations in the upper and lower reservoirs, respectively, 
Clow,0 and Cup,0 are the initial concentrations in each reservoir, D is the diffusion coefficient, t is 














&&   (3.4) 
where A is the area of the clot through which dextran diffusion occurs, H is the void fraction of 
the stainless steel mesh support, L is the diffusion length equal to the thickness of the clot, Vlow is 
the volume of the lower reservoir, and Vup is the volume of the upper reservoir.  
3.3.8 Statistical Analysis 
A line was fit to the plot of the normalized flow rate (µQ/A) as function of the pressure 
gradient (ΔP/L) using the Matlab routine robustfit, which uses iteratively reweighted least 
squares with a bisquare weight function. The slope of that line was reported as the permeability 
according to Darcy’s law, Eq. 3.1. The uncertainly in the permeability is reported as the standard 
error of the fit. All other data is presented as the mean ± standard deviation. A weighted sum 
least squares parameter was used to compare model predictions of permeability to experimental 
data. The weighted residual was defined as:  
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 (3.5) 
where FEi is the fractional error of the ith component, ki is the ith measured permeability, 𝑘! is 
the theoretical permeability.  The sum of squares of the fractional error is used to determine the 
goodness of fit parameter (χ2): 
 (3.6) 
3.4 Theory 
A series of theoretical models have been developed to predict both permeability and 
hindered diffusivity as a function of fibrin and platelet densities based on empirical relationships, 
the solutions to the equations of Stokes flow, and computer models.  
3.4.1 Permeability of fibrin gels 
Numerous analytical, computational and empirical relationships have been developed to 
predict the permeability of fibrous media (101-108). Most of these relationships have the general 
form of: 
 (3.7) 
where kf is the permeability, af is the fiber radius, and ϕf is the fiber volume fraction. In this study 
we compare our experimental measurements of permeability for fibrin gels with three models. 
The first model is the Davies’ equation, which is an empirical relationship based on air flow 
through fibrous media at low Reynolds numbers (109):  
 (3.8) 
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ki − ki( )
ki







2 = f φ f( )
k f
a f
2 = 16φ f




Eq. 3.8 has been commonly used to estimate the permeability of fibrin gels and blood clots (19, 
20, 56, 110). The second model by Jackson and James is the weighted average of the solution to 
Stokes equation for flow parallel to or normal to two-dimensional periodic square arrays of 
cylinders (103): 
  (3.9) 
The third model comes from Clague and colleagues who used the lattice Boltzman (LB) method 
to calculate the permeability of random fibrous media (111).  We used Eq. 14 from 
reference (111) which is their solution for an array of disordered fibers: 
 (3.10) 
Eq. 3.10 gives the appropriate scaling of the permeability over a wide range of fiber volume 
fraction (0.05−0.7). To compare these three models to our experimental data, it is necessary to 
estimate the fiber volume fraction, ϕf, of the fibrin gels and the fiber radus, af, as a function as 
fibrinogen concentration, cFbg. The fiber volume fraction was calculated using a mass balance 
where we assumed that all the fibrinogen was incorporated into a fiber and that each individual 
fiber consists of an internal solid fraction, Φint, and water fraction, 1-Φint. The internal solid 
fraction, Φint, was estimated from neutron scattering data collected from fibrin gels formed at 
fibrinogen concentrations of 1−40 mg/mL (86). A fit of the data from Fig. 5 in reference (86) 
gives: 
 (3.11) 
where cFbg is in mg/mL. We extrapolated Eq. 3.11 out to 155 mg/mL since, to the best of our 






























Φint = 0.015ln cFbg( )+ 0.13
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higher fibrinogen concentrations this trend may not hold, but given the weak dependence of 
internal solid fraction on fibrinogen concentration, any deviations should be small.   
The overall fiber volume fraction (ϕf) is calculated by:  
 (3.12)  
The mass density of an individual fibrinogen protein (ρm) is 1.4 g/mL (112).  
The dehydrated fiber radius was determined by analysis of SEM images as described in 
Section 3.3.5. The hydrated fiber radius (af) was calculated by: 
 (3.13)  
where ad is the dehydrated radius. We assume that there is no void space in the dehydrated fibers. 
3.4.2 Permeability of platelet rich clots 
In platelet rich clots, viscous losses on the platelet surface will contribute to the overall 
hydrodynamic resistance through the clot in conjunction with losses on fibrin fibers. Platelets 
also increase the superficial velocity within the fibrin gel and increase the tortuosity. Platelet rich 
clots have elements of both granular (platelets) and fibrous (fibrin) media. Similar to the 
treatment of fibrin gels described above, we compared our experimental data to three models that 
account for this type of mixed porous media.  
In the first model, we treat the granular and fibrous media components as independent 
hydraulic resistances and add their contributions in parallel as an unweighted resistivity: 
 (3.14) 
where kt is the overall permeability, kp is the permeability of the platelets, and kf is the 


















unweighteed resistivity was found to be the most accurate method of averaging permeabilities in 
bimodal mixtures of fibers of different radii (108). We measured kf directly from bovine platelet 
poor plasma. We estimate kp using the Kozeny-Carmen equation for packed beds (113): 
 (3.15)
 
where, Ψ is the sphericity, ϕp is the platelet volume fraction and ap is the platelet radius. The 
diameter of a bovine platelet is ~1 µm. Sphericity was calculated by assuming platelets are flat 
cylinders with a diameter of 1 µm and a height of 100 nm: 
 (3.16)
 
where Vp is the platelet volume and Ap is the platelet surface area.  
The second model we considered was the fractional packing model which was developed 
to describe porous media with a mixture of coarse and fine grains (114). In the fractional packing 





where kt is the total permeability, ϕt is the total volume fraction of solids, Ψ is the sphericity, and 
ac is the effective characteristic length.  
The third model we considered was developed by Ethier and considers a two-component 
































blood clots because the radius of fibrin fibers (50−100 nm) is much smaller than the size of 
single platelet (1 µm). In the model, flow through the media is described using the higher-order 
Brinkman equation rather than Darcy’s law:  
 (3.19)
 
where µ is the fluid viscosity, v is the fluid velocity, kf is the fibrin permeability and P is the 
pressure. In the Ethier model, the composite medium can be thought of as a matrix of fine fibers 
embedded with large solid inclusions. The no-slip boundary condition on these large inclusions 
is satisfied by the Laplacian term in Eq. 3.19. Experimental measurements of permeability of 
PRC were compared to the unit-cell matching in Fig. 3b of reference (115). Note that Eq. 3.19 is 
only applicable at length scales where the pressure gradient is balanced by the Laplacian of the 
velocity. This length is often referred to as the Brinkman screening length, and is equal to the 
square root of the permeability, kf.   
In all three of the mixed porous media models described above, the void fraction of the 
clot, ε, was calculated by: 
 (3.20)
 
where ε is the void fraction of the clot, ϕp and ϕf are the volume fractions of the platelets and 
fibers, respectively. The platelet volume fraction was estimated based on calculations of the 
maximum packing of circular disks and verified by image analysis of confocal images of PRC as 
described in section 3.3.6. The volume fraction of the fibers was calculated using Eq. 3.12. 
3.4.3 Hindered diffusion 
One model used to describe the hindered diffusivity of solutes presented by Phillips 
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effective medium model initially presented by Phillips and Brady with a refinement aimed 
toward steric hindrance later made by Johnson et al. (62, 94). Phillips derived an expression for 




= FS  (3.21) 
where D is the diffusion coefficient of the solute in the clot, D0 is the diffusion coefficient of the 
solute in free solution, and F and S are terms accounting for hydrodynamic and steric hindrances, 
respectively. The degree of hydrodynamic hindrance is determined by calculating the drag force 
imparted by a sphere on a parallel array of fibers: 














where d is the diameter of the solute and, k, is the permeability of the medium (94). Steric 
hindrance is determined based on computer simulations calculating the diffusivities of a 
molecule moving through random, overlapping arrays of polymer chains assuming no 
hydrodynamic interactions: 

















where ϕ is the solids fraction of the medium, df is the diameter of a fiber in the medium, and d is 
the diameter of the solute as above (116). Essentially, steric hindrances are accounted for by 
adjusting the overall solid fraction to account for the finite size of the solute.  
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3.5 Results 
Both the permeability and hindered diffusivity of fibrin gels and platelet rich clot were 
found to vary greatly with fibrin volume fraction. However, both properties were most sensitive 
to solid fraction in fibrin gels in the dilute limit whereas the greatest sensitivity in platelet rich 
clots occurred at higher solid fractions. 
3.5.1 Permeability of fibrin gels 
 Fibrin gels were made from 3−156 mg/mL fibrinogen solutions with 10 nM thrombin 
(Table 3.1). The permeability of each gel was calculated using Darcy’s law, Eq. 3.1. 
Measurements were made at least three pressures gradients for each fibrinogen concentration. It 
was necessary to increase the magnitude of the pressure gradient concomitantly with fibrinogen 
concentration in order to achieve flow rates that could be measured over a reasonable time 
(Table 3.1). Experiments were conducted with food dye added to the permeation buffer in order 
visualize the permeation front. For each gel, we measured the failure pressure which was defined 
Table 3.1. Permeability of fibrin gels. Fibrin gels were made from fibrinogen solutions using 
10 nM thrombin and 2.5 mM CaCl2. Fiber volume fractions, ϕf, were calculated from Eq. 3.12. 
The hydrated fiber radius, af, was calculated from Eq. 3.13 using a dehydrated fiber radius of 23 
nm. Flow was induced through the fibrin gels by pressure gradients that range from ΔP/L 
[Pa/m]min to ΔP/L [Pa/m]max. The permeability is reported as a fit to Eq. 3.1 with uncertainty 
estimated by the standard error (SE) of the fit. The effective screening length is the square root of 
the measured permeability. 















.02 3 60 3×104 - 1×105 120 (15) 346 
.03 7 58 8×104 - 1×105 52 (14) 228 
.04 10 57 7×104 - 1×105 22 (3) 148 
.08 20 55 8×104 - 5×105 7.0 (0.2) 84 
.10 24 55 3×105 - 7×105 3.4 (0.6) 58 
.18 48 53 4×105 - 2×106 0.73 (0.02) 27 
.25 67 52 4×105 - 2×106 0.57 (0.07) 24 
.27 72 52 7×105 - 2×106 0.51 (0.15) 23 
.32 89 52 4×105 - 2×106 0.44 (0.04) 21 
.35 96 52 8×105 - 2×106 0.33 (0.09) 18 
.43 121 51 8×105 - 2×106 0.27 (0.12) 16 
.54 156 51 8×105 - 3×106 0.15 (0.02) 12 
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as the pressure at which the gels either breaks apart or tears away from the tube wall. These 
failure events were clearly visible due to uneven distribution of the dye. For permeability 
measurement experiments the maximum pressure for each gel was 40%-60% of the failure 
pressure. The flow rate for each gel was measured at three pressures. The calculated permeability 
was independent of pressure over the range used in these measurements.  
An increase in fiber volume fraction with increasing fibrinogen concentration was 
observed by confocal microscopy (Fig. 3.1). Gels made of 3−10 mg/mL fibrinogen consist of 
 
Figure 3.1. Fibrin gel morphology as a function of fibrin density.  Fibrin gels were made at 
various fibrinogen concentrations using 10 nM thrombin and imaged by confocal microsocpy.  
Gels consisted of unlabeled fibrinogen and fluorescent labeled fibrinogen at a ratio 1000:1 
unlabeled:labeled. Final fibrinogen concentration of gels: (A) 3 mg/ml; (B) 10 mg/ml; (C) 20 
mg/ml; (D) 40 mg/ml; (E) 60 mg/ml; (F) 100 mg/ml.  Scale bar = 20 µm 
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fibers spaced as far apart as ~10 µm within a given plane. The effective hydrodynamic screening 
length for these gels, estimated as the square root of the permeability, is 148−346 nm (Table 3.1). 
Gels of 20−24 mg/mL fibrinogen consist of a dense mat of fibers with fibers spaced as far apart 
as ~1 µm within a given optical plane. These gels have an effective hydrodynamic screening 
length of 58−83 nm. Gels of 67 mg/mL and greater have no discernable porous structure at the 
resolution of the microscope and have an effective hydrodynamic screening length of 27 nm or 
less. The fiber volume fraction ranges from 0.02 (3 mg/mL) to 0.54 (156 mg/mL) as calculated 
by Eq. 3.12. 
Dehydrated fiber radii were measured by SEM and were found to be relatively insensitive 
to fibrinogen concentration (Fig. 3.2). For example, the average fiber radius at 7 mg/mL 
fibrinogen was 21 ± 6 nm and the average fiber radius at 72 mg/mL was 24 ± 8 nm. Based on 
these measured values, we used 23 nm as an average dehydrated fiber radius for all fibrinogen 
 
Figure 3.2.  Fibrin fiber diameter as a function of fibrinogen concentration.  Scanning electron 
micrographs were taken of fibrin gels as various fibrinogen concentrations to enable the 
measurement of fiber radius, ad: (A) 7 mg/ml; (B) 48 mg/ml; (C) 156 mg/ml; (D) Measured 
dehydrated radii of fibrin fibers.  Scale Bar = 500 nm. 
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concentrations. The hydrated average fiber radius (af) was calculated using Eq. 3.13 (Table 3.1). 
The hydrated fiber radius for each fibrinogen concentration was used for permeability 
calculations using the models described by Eqns. 3.8, 3.9, and 3.10.  
The permeability of fibrin gels spans three orders-of-magnitude over a fiber volume 
fraction range of 0.02 to 0.54 (Table 3.1). The permeability was most sensitive to volume 
fraction over the range 0.02–0.18, which corresponded to permeabilities of 1.2×10−1 µm2 to 
7.3×10−4 µm2.  Over the volume fraction range of 0.18–0.54 the change in permeability was 
more modest, varying from 7.3×10−4 to 1.5×10−4 µm2. These observations are in agreement with 
models of fibrous media that show a linear sensitivity to volume fraction over the range of 
0−0.05 compared to ln(ϕf)/ϕf sensitivity to volume fraction over the range of 0.05−0.6 (104).  
The measured dimensionless permeability (kf/af2) of fibrin gels was compared to 
predictions from three models of three-dimensional disordered fibrous media; the semiempirical 
Davies equation, Eq. 3.8, the Jackson and James expression which is a weighted average of 
analytical solutions for flow parallel and perpendicular to an array of cylinders, Eq. 3.9, and LB 
simulations for flow through disordered fibers, Eq. 3.10. Equations 3.9 and 3.10 are solutions to 
Stokes flow past arrays of periodic or randomly oriented cylinders, respectively. In the semi-
dilute limit (ϕf < 0.2), all three models are in good agreement with the measured permeabilities 
(Fig. 3.3). The Jackson and James model asymptotically approaches zero as the volume fraction 
approaches 0.4. Both the Davies equation and LB simulations are in good agreement with 
experimental values over the entire range of volume fractions with χ2 values of 15 and 5, 
respectively. Based on these comparisons, we conclude that fibrin gels over a fiber volume 
fraction of 0.02-0.54 are well described by models of disordered, cylinders with uniform 
diameters. 
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3.5.2 Permeability of platelet rich clots 
Platelet rich clots (PRC) were formed by adding 10 nM thrombin to platelet suspensions 
in plasma with cell densities of 7×105/µL to 5×107/µL. There was no visual evidence of platelet 
aggregation during the preparation of PRC prior to the addition of thrombin. The platelet volume 
fraction range was estimated based on analysis confocal microscopy images (Fig. 3.4) and 
spanned the range of 0.01 to 0.61 (Table 3.2). The permeability of PRC decreased by three 
orders-of-magnitude over this range of platelet volume fraction. The permeability of bovine 
plasma clotted with 10 nM thrombin in the absence of any platelets was 
1.2 × 10−2 ± 0.6 × 10−2 µm2. We did not observe a contribution of the platelets to the 
permeability for platelet volume fractions of less than 0.19 (Table 3.2). At a platelet volume 
fraction of 0.19−0.31 we observed a modest contribution of the platelets to permeability with 
~50% decrease compared to a pure fibrin gel. At higher platelet volume fractions (>0.31) the 
 
Figure 3.3.  Comparison of fibrin gel permeability to fibrous media models.  The experimentally 
measured dimensionless permeability (kf/af2) of fibrin gels (!) compared with the Davies’ 
Equation, Eq. 3.8 (— —); Jackson and James (- -), Eq. 3.9 ; lattice Boltzmann simulation results, 
Eq. 3.10 (⎯). Error bars represent standard deviations. 
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contribution of the platelets begins to dominate the overall hydraulic resistance. The permeability 
of a PRC with a platelet volume fraction of 0.37 was an order of magnitude less that that of a 
pure fibrin gel, decreasing from 1.5 × 10−2 µm2 to 1.1 × 10−3 µm2.  
We compared experimental results to three mixed porous media models; a resistors-in-
parallel model, Eq. 3.14, a fractional packing model, Eq. 3.17, and Ethier’s numerical 
calculations of the Brinkman equation for fibrous media with two dissimilar radii (Fig. 3.5). The 
resistors-in-parallel model treats the PRC as two independent and non-interacting media—a 
 
Figure 3.4.  Platelet rich clots morphology as function of platelet density.  Platelet rich clots 
were made with platelets diluted into platelet poor plasma containing labeled fibrinogen and 
imaged by confocal microscopy. Clotting was induced with 10 nM thrombin. The volume 
fraction of platelets,ϕp, for each panel is (A) 0.61; (B) 0.45; (C) 0.31; (D) 0.19; (E) 0.05; (F) 
0.01.  Scale Bar = 20 µm. 
 57 
fibrous medium defined by fibrin and granular medium defined by platelets where the overall 
permeability is calculated by adding the resistances of each medium in parallel. We used the 
measured permeability of a fibrin gel from bovine plasma and estimated the platelet permeability 
using the Kozeny-Carmen equation, Eq. 3.15. The resistors-in-parallel model provides a good 
estimate of the permeability over most of the range of platelet volume fractions but begins to 
deviate as the platelet volume fraction increases beyond 0.3.  The χ2 for this model is 0.95. 
The fractional packing model assumes that the PRC can be treated as homogeneous 
porous medium based on a volume weighted volume fraction and a characteristic radius. A 
characteristic radius of 214 nm was calculated by taking the harmonic mean of the diameter of a 
fiber and the diameter of platelet. We calculated the characteristic radius based on the size of 
platelet aggregates (Table 3.2) as well, but there no appreciable difference between these values 
and those based on a single platelet. The permeability was then estimated using the 
Kozeny-Carmen equation Eq. 3.15. The fractional packing model predicts that the permeability 
is much lower than the measured values over nearly the entire range of platelet volume fractions.  
Table 3.2.  Permeability of platelet rich clots. Platelet rich clots (PRC) were made from solutions 
of platelets diluted into platelet poor plasma and clotted with 10 nM thrombin in the presence of 
2.5 mM CaCl2. Platelet volume fractions, ϕp, were calculated from confocal microscopy images. 
Flow was induced through the thrombi by pressure gradients that range from ΔP/L [Pa/m]min to 
ΔP/L [Pa/m]max. The radii of platelets and platelet aggregates, ap, were estimated from confocal 
microscopy images of PRC. The permeability, kt, is reported as a fit to Eq. 3.1 with uncertainty 


















0.01 (0.004) 7×105 1 (.2) 3×104 - 8×104 11 (0.98) 105 
0.05 (0.01) 1×106 1 (.3) 3×104 - 8×104 12 (0.96) 110 
0.19 (0.02) 7×106 4 (4) 3×104 - 8×104 6.7 (0.83) 82 
0.31 (0.04) 1×107 8 (3) 3×104 - 8×104 6.1 (0.69) 78 
0.37 (0.05) 2×107 16 (5) 6×104 - 2×105 1.1 (0.53) 33 
0.45 (0.02) 4×107 17 (6) 1×105 - 4×105 0.20 (0.020) 14 
0.61 (0.06) 5×107 26 (6) 1×105 - 2×106 0.015 (0.0019) 4 
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At low platelet volume fraction (<0.1), the model overestimates the permeability as the PRC 
approaches a pure fibrin gel. Consequently, the fractional packing model is a poor fit with 
χ2 = 500. This suggests that PRC cannot be reduced to a porous medium with a single 
characteristic length scale over a large range of platelet volume fractions. 
Comparison of the data with the Ethier model shows that a PRC is well described as a 
Brinkman medium. The best fit of Ethier’s calculation to the experimental data occurs when 
kf/acoarse2 is close to unity (Fig. A-4), where acoarse is the radius of the coarse media (platelet 
aggregates). The χ2 value for this model equals 0.82. The calculated value of kf/acoarse2 is ~0.01, 
based on the permeability of bovine plasma and the size of single platelet. This discrepancy 
suggests that kf may be larger in a PRC than in a fibrin gel in the absence of platelets. One 
explanation for a higher permeability is that some of the fibrinogen or fibrin monomers are 
bound to αIIbβ3 receptor on activated platelets, and thus are not available for polymerization into 
 
Figure 3.5.  Comparison of platelet rich clot permeability to mixed porous media models. The 
experimentally measured permeability, kt, of platelet rich clots (!) compared with the resistor-in-
parallel model, Eq. 3.14 (— —); the fractional packing model (- -), Eq. 3.17; Ethier’s solution 
for kf/acoarse2 = 1 (⎯). Error bars represent standard deviations. 
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fibers. There are ~80,000 αIIbβ3 receptors per platelet (117). At a platelet density of 107/µL, the 
ratio of αIIbβ3 receptors to fibrinogen molecules is roughly 1:1, so the probability that a 
significant fraction of fibrin(ogen) is bound to platelet surfaces seems feasible. Comparison of 
confocal images of fibrin in the presence and absence platelets confirms that platelets affects 
fibrin polymerization (Fig. A-5). Fibers in the presence of platelets appear much shorter than in 
platelet poor plasma. 
Because the Ethier model incorporates the volume fraction of fibrin and platelets as 
independent parameters, we can use these solutions to predict the total permeability of a clot 
based on the volume fractions of each component. Fig. 3.6 shows the predicted permeability of a 
clot as a function of platelet volume fraction at constant fibrin volume fractions. The fibrin 
permeability, kf, was calculated using Eq. 3.10 since this gave the best fit to the experimental 
data.  The measured platelet aggregate diameter, acoarse, was used to determine the appropriate 
value for kf/acoarse2. The total permeability, kt, was then estimated from Fig. A-3.  
The transition from a fibrin rich medium described by an array of uniform cylinders a to platelet 
rich medium described by Brinkman’s equation accounts for viscous losses on the surface of 
platelets. The criteria under which these viscous losses become significant can be estimated by 
considering the simple scenario of unidirectional flow through a fibrin gel between two parallel 
plates that represent two platelets spaced a distance h apart is (see Appendix A.1 for derivation 
(72)). Assuming the flow is described by Eq. 3.19 the total permeability is:  
 (3.24) 
The first term in Eq. 3.19 represents Darcy’s law and the second term is the Brinkman 
correction. Note that as " 0, the total permeability approaches the fibrin permeability 
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and Darcy’s law describes interstitial flow in the space between the two plates. The effect of the 
platelets on the interstitial velocity is only most significant for  < 0.05. Thus, as the fibrin 
volume fraction increases the total permeability becomes less sensitive to platelet volume 
fraction.  This is shown in Fig. 6 when comparing low and high fibrin volume fractions. For the 
case of ϕf = 0.03 the permeability of a clot will decrease by over two orders-of-magnitude as φp  
ranges from 0.01 to 0.6. For the case of φ f  = 0.55 the permeability of a clot will decrease only 
three-fold as ϕp ranges from 0.01 to 0.6.  
Viscous losses alone do not account for the effect of the addition of platelets into a fibrin 
gel. Note that we begin to observe decrease in the permeability at a ϕp = 0.19 (Table 3.2). The 
effective screening length of bovine plasma (kf-0.5) is 109 nm, which based on the argument 
presented above suggests that platelets need to be ~2.2 µm apart to influence the permeability. 
k f / h
 
Figure 3.6.  Estimated permeability of blood clots as a function of platelet and fibrin volume 
fractions.  The permeability of a blood clot was calculated using a combination of Ethier’s 
solutions to the Brinkman equation (Fig. A-3) and Clague’s solution for random fibrous media, 
Eq. 3.10. Each line represents the total permeability, kt, at constant fibrin volume fraction, ϕf, as a 
function of platelet volume fraction, ϕp. 
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However, inspection of PRC images at ϕp  = 0.19 (Fig. 3.4D) show that gaps exist between 
platelets on the order of 10 µm. The influence of platelets at lower volume fractions than 
predicted by Eq. 3.24 is a result of an increase in tortuosity and an increase in superficial velocity 
within the fibrin gel. In the limit of low fibrin permeability or large platelet aggregates 
(kf/acoarse2 ! 0), Ethier’s solution to the Brinkman equation reduces to: 
 (3.25) 
The numerator represents the area obstruction by platelets and platelet aggregates, and leads to 
an increase in superficial velocity in the fibrin gel. The denominator represents the increase in 
the tortuosity of the fluid path due to the platelets and platelet aggregates. Eq. 3.25 correctly 
predicts the influence of platelets over the range of ϕp from 0.01 to 0.31. For example, at 
ϕp = 0.19, Eq. 3.25 predicts a permeability of 8.0 × 10-3 µm2, which is close to the measure value 
of 6.7 × 10-3 µm2. At φp  ≥ 0.37, Eq. 3.25 overestimates the permeability, suggesting that viscous 
losses begin to play a role at these higher platelet volume fractions. 
3.5.3 Hindered diffusion in fibrin gels and platelet rich clots 
Fibrin gels and platelet rich clots identical to those formed for permeability 
measurements were formed for hindered diffusion measurements. The diffusion coefficients of 
12, 29, and 54 nm solutes (70 kDa, 500 kDa, 2000 kDa dextrans) in fibrin gels and PRC were 
significantly hindered compared to free solution for all solutes. In 100 mg mL-1 fibrin gels we 
observed 60%, 66% and 85% reductions of diffusion coefficients for 12, 29, and 54 nm solutes, 
respectively. Similar to the trend observed with the permeability, hindered diffusivity was most 
sensitive to volume fraction over the range 0.02–0.18 for all probes tested. This is expected, as 
the permeability is an indirect measure of pore size. The Phillips model (Eq. 3.21) was used to 










predict the diffusion coefficient of the 12, 29, and 54 nm probes using the measured permeability 
as a model input (Fig. 3.7A). The Phillips model predicted the hindered diffusivity well for the 
29 and 54 nm probes, but overestimated the diffusivity of the 12 nm probe at higher fibrinogen 
concentrations. The diffusion coefficient of a 70 kDa dextran in a PRC decreased by as much as 
93% compared to free solution as platelet volume fraction was increased to 0.61. The Phillips 
model was used to accurately predict the degree of hindrance using the measured permeability as 
a model input (Fig 3.7B). Similar to the trend observed in permeability, the majority of the 
hindrance occurred above platelet volume fraction of 0.3.   
3.6 Discussion 
The objective of this study was to measure the permeability of fibrin gels and platelet rich 
clots over a wide range of fibrin and platelet densities. Fibrin gels were formed using a range of 
fiber volume fractions of 0.02−0.54, resulting in permeabilities of 0.12−1.5×10−4 µm2. PRC were 
formed in plasma (~7 mg/mL fibrinogen) at platelet volume fractions of 0.01−0.61, resulting in 
 
Figure 3.7. Diffusion in fibrin gels and platelet rich clots. Measured diffusivity of 12 ( ), 
 29 (◦), 54 (▽) nm probes (70 kDa, 500 kDa, 2000 kDa dextrans) in (A) fibrin gels and (B) 
platelet rich clots compared the Phillips model, Eq. 3.21 
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permeabilities of 1.1×10−2 −1.5×10−5 µm2. These data suggest that the interstitial flow within 
clots will vary widely depending on their structure. Fibrin gels were well described as a Darcy 
medium consisting of disordered fibers with a uniform diameter. PRC were best described as a 
Brinkman medium of platelets embedded in a fibrin gel. Diffusion coefficients were reduced in 
fibrin gels with 100 mg mL−1 fibrin gels reducing diffusion coefficients by 60%, 66%, and 85% 
for 70 kDa, 50 kDa, and 2000 kDa probes, respectively. PRC also reduced solute diffusion; the 
diffusion coefficient of a 70 kDa dextran was reduced by as much as 93% compared to free 
solution as platelet volume fraction was increased to 0.61. Hindered diffusion in both fibrin gels 
and PRC was adequately described by the Phillips model using the measured permeability as a 
model input.    
Permeability and solute diffusivity measurements of fibrin gels at low fibrinogen 
concentration (3−10 mg/mL) in this study are in good agreement (within 25%) of previously 
reported values of permeability and free solute diffusivity (19, 118). The volume fraction of 
fibers in gels made at plasma fibrinogen concentrations is less than 0.05. However, analysis of 
retracted clots from humans suggests that fibrin can make up a large fraction of the solids in 
arterial clots.  For example, the solid fraction of emboli retrieved from patients with atrial 
fibrillation were reported to consist of 65% fibrin and the balance platelets (96). Similarly, 
electron microscopy analysis of the solid fraction of acute myocardial infarction clots show that 
these clots consist of 56% fibrin, 17% platelets and the balance other blood cells (31). These data 
are evidence that the volume fraction of interstitial fibrin within a clot is likely much higher than 
that of clot formed at plasma concentrations of fibrinogen, and in some types of clots, the fibrin 
fibers are likely the major transport barrier to fluid and solute transport. Based on these data from 
extracted clots we would predict that the permeability of fibrin rich clots such as these have 
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permeabilities in the range of 10−3 −10−4 µm2, two to three orders-of-magnitude less than fibrin 
gels made at physiological fibrinogen concentration, and that solute diffusion within such clots 
would be hindered by over 50%.  
Modeling the permeability and hindered diffusivity within fibrin gels requires the 
measurement of fibrin diameter and fiber volume fraction. Fibrin fiber diameter was relatively 
insensitive to fibrinogen concentration over the range of 3−156 mg mL−1. Neutron scattering 
studies of fibrin fibers formed from solutions of 2−40 mg/mL fibrinogen noted a similar 
insensitivity to fibrinogen concentration (86). The average hydrated fiber radius we measured 
over all fibrinogen concentrations was between 51−60 nm. This range is in good agreement with 
the maximum fiber radius of ~50 nm caused by the twisting of protofibrils (119). However, these 
radii are slightly lower than those measured by neutron scattering over a similar range of 
fibrinogen concentrations (60−70 nm), albeit with deuterated water. This could be a result of the 
assumption that there was no void space in the dehydrated fibers. If there were some voids 
within the fibers following fixation and dehydration preparation for SEM, then we would have 
underestimated the hydrated radius. It should be noted that this is the size of an individual fiber, 
but fibers can aggregate to yield effective fiber diameters of 100−300 nm (19). Thus, one 
potential source of error between the normalized permeability (kf/af2) and hindered diffusivity 
based on our measurements and those predicted in the fibrous media models is that we have 
assumed the appropriate characteristic length is the radius of an individual fiber. Nevertheless, it 
seems that transport through fibrin gels is well described by theories of flow and resistance 
through a network of three-dimensional disordered cylinders.  
The permeability of fibrin gels over the entire range of fiber volume fractions were well 
described by several models of fibrous media. The semi-empirical Davies equation has been 
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commonly used to estimate the permeability of fibrin gels and blood clots in the literature (20, 
56, 110). Here, we found the Davies equation had excellent agreement with experimental 
permeability at fiber volume fractions of 0.006 to 0.3, but underestimates the permeability at 
higher fiber volume fraction. The Jackson and James expression is another common expression 
used for three-dimensional fibrous media. Similar to the Davies equation, the Jackson and James 
expression accurately predicts permeability in the semi-dilute regime but approaches zero as the 
volume fraction approaches 0.4 due to the fact that this expression is based on asymptotic 
expansions in the dilute limit. The LB simulations presented by Clague and colleagues and found 
that there was good agreement over the entire range of fiber volume fractions measured 
experimentally. Therefore, we used Eq. 3.10 for calculating both fibrin gel permeability and the 
fibrin contribution to the overall permeability in PRC. Unlike the Jackson and James expression, 
Eq. 3.10 captures the appropriate scaling behavior in both the dilute and concentrated fiber 
volume fraction limits. In the dilute limit, the permeability scales as ln(ϕf)/ ϕf. In the concentrated 
limit, the permeability scales according to the lubrication approximation (101, 104). 
Hindered diffusivity over the entire range of fiber volume fractions was well described by 
the Phillips model. Because the Phillips model uses permeability as a direct model input the 
agreement between the model and the measured values indicates a direct relationship exists 
between permeability and hindered diffusivity and that measured values of permeability provide 
a good approximation of the pore size of a clot. 
One potential limitation of the data in this study is that fibrin gels were formed under 
static conditions, resulting in an isotropic medium of randomly oriented fibers. However, there is 
evidence that flow may effect the orientation of fibrin fibers. For example, in a purified system 
consisting of fibrinogen and thrombin it was found that ability of fibrin fibers to form and 
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aggregate, as well as their orientation, is profoundly influenced by the shear rate and rate of 
thrombin generation (120). Similarly, flowing plasma over activated platelets or tissue factor 
presenting cells also showed that fibrin fibers tend to align in the direction of flow (120, 121). 
Finite element simulation of flow through networks of aligned fibers predict that the 
permeability in the direction parallel to fibers will be higher than in an isotropic network but that 
there is little difference in permeability for aligned and isotropic networks for flow perpendicular 
to fibers (107). The noted dependence of permeability upon alignment in these studies, however, 
was shown to be secondary compared to fiber diameter and fiber volume fraction.  Random walk 
simulations of solute diffusion through fibrous matrices of various orientations and degrees of 
alignment indicate that, although the overall hindered diffusion coefficient is not affected by 
fiber orientation, diffusion anisotropy with preference for solute movement parallel to the fibers 
exists in aligned networks (122). The magnitude of anisotropy observed in these studies resulted 
in diffusion rates in the direction parallel to highly-aligned fibers being as much as 60% greater 
than in the transverse direction depending upon degree of alignment and ratio of solute diameter 
to fiber diameter. If these predictions held for fibrin rich clots, then the permeabilities presented 
in this study for isotropic fibrin gels could slightly underestimate the permeability and diffusion 
coefficients in the direction of flow. 
Clots formed in large arteries or stenosis can consist of large volume fractions of 
platelets. For example, ~33% of thrombi formed on ruptured coronary plaques consist of a 
majority of platelets (123). Clots formed in vitro in a model of a stenotic artery consist of up to 
80% platelets (124). Yet, there have been few measurements of permeability or hindered 
diffusivity of fibrin gels with a significant (>0.2) volume fraction of blood cells. Clots formed at 
a fibrin volume fraction of 0.03 had an exponential decrease in permeability and up to a 93% 
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reductions of diffusion coefficients with increasing platelet volume fraction over the range of 
0.2 < ϕp < 0.6. A resistor-in-parallel model that takes into account the viscous losses on the 
platelets in parallel to those on the fibrin fibers provides a good first-order estimate of the 
permeability of PRC. However, the more rigorously derived Ethier model based on the 
Brinkman equation provides at least better qualitative treatment of the interplay between fibrin 
and platelets as platelet volume fraction increases. Specifically, increases in platelet volume 
fraction result not only in viscous losses on the platelet surface, but also results in an increase of 
the tortuosity of the flow path and in an increase superficial velocity of the fluid through the 
fibrin gel. Below a platelet volume fraction of 0.2, platelets play only a limited role in 
determining permeability and hindered diffusivity and the fibrin permeability provides a good 
estimate of the overall transport of the PRC. This is in agreement with the influence of 
erythrocytes in fibrin gels, which resulted in no significant difference in permeability up to a 
volume fraction of 0.2 (125).  
A limitation of using the Ethier model to describe PRC is that it describes a medium 
consisting of two cylinders with dissimilar radii. Here, we have applied it to a medium consisting 
of fine fibers and larger disc or spherical particles. One difference between cylinders and spheres 
is that the drag force on a sphere is larger than on a cylinder with the same radius for low 
Reynolds number flows. Consequently, the effective coarse fiber radius in the Ethier model 
would likely be smaller than that of a platelet or platelet aggregate. We may have indirectly 
accounted for this difference because a larger value of kf/acoarse2 was needed to fit our 
experimentally measured permeability than would be predicted by the measured values of kf and 
acoarse. The authors are unaware of any theoretical treatment of spherical or elliptical objects 
embedded in a fibrous medium with which we could compare our experimental results. 
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Similarly, the Phillips model of hindered diffusion assumes the medium to be comprised 
of an array of cylinders with a uniform diameter. This assumption is valid for fibrin gels, but 
breaks down for PRC and may be a source for the disagreement between the model and the 
measured diffusion coefficients. In particular, the steric hindrance terms of the Phillips model 
calculates effective solid volume based on the volume to length ratio of a long cylinder with a 
constant radius; however, platelets not fibers, make up a majority of the solid volume fraction of 
a PRC. This may lead to an over estimation of the effective solid volume and thus an 
underestimation of the diffusion coefficient. This discrepancy is most pronounces at low solid 
volume fractions where the steric term dominates. At high solid fraction (> 0.45) the 
hydrodynamic term of the Phillips model dominates; therefore, inaccuracies due to incorrect 
estimation of the steric hindrance is minimal. 
Within a clot the distribution of platelets and fibrin can be heterogeneous. For example, 
histology of clots retrieved from individuals with ischemic stroke show thin layers of fibrin-
platelet interspersed with erythrocytes and leukocytes (97). The nature of an injury also will 
affect the clot composition. Shallow injuries that expose the collagen rich extracellular matrix 
underneath endothelial cells will primarily promote platelet adhesion and aggregation. Deeper 
injuries can expose tissue factor (TF) bearing adventitial cells such as fibroblasts and smooth 
muscle cells, which can induce coagulation and thus produce more fibrin. Intravital microscopy 
in the murine laser injury model of thrombosis show that fibrin density tends to be greatest near 
the vessel wall and on the upstream edge of a clot during the initial stages of clot 
formation (126). Platelets within the interior of a clot form a densely packed core that may be 
impermeable to fluid and solute transport (127). Platelets along the periphery of the clot are less 
densely packed. This heterogeneity in platelet density seems to reflect platelet activation because 
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P-selectin positive platelets are observed in the core closest the site of injury (128). A 
morphology of a dense core of activated platelets surrounded by a more loosely packed 
inactivated platelets is also predicted in computational models (34, 56). These data suggest that 
there are regions of a clot, notably the outside shell of platelet and fibrin that are more permeable 
and hinder diffusion less, and thus subject to an evolving biochemical environment that includes 
the influx and removal of plasma and coagulation proteins. The data from this study can be used 
as a look-up-table of permeabilities and hindered diffusivities for different regions of clot within 
these computational models.  
3.7 Conclusions 
In this study we have examined a broad range of fibrin and platelet densities in an effort 
to bound the possible compositions of clots formed during the initial stages of hemostatic and 
thrombotic clots. We found that a combination of fibrous media models and mixed porous media 
models can be used to predict the permeability of clots over a wide range of fibrin and platelet 
volume fractions. Fibrin gels or platelet poor clots are well described as a medium of disordered 
fibers with a uniform diameter. Clots with significant volume fractions of platelets greater than 
0.2 are best described as a Brinkman medium. Permeability models can, in turn, be used to 
predict hindered solute diffusivity in a clot. Using permeability as a model input, the Philips 
model, accounting for both steric and hydrodynamic hindrance, can be used to predict hindered 
diffusion within clots formed with a wide range of compositions. These models can be used to 
make predictions on the rate at which fluid and solutes can move through the interstitial spaces 
of a clot. Such predictions are important for estimating the rate of coagulation 
zymogens/enyzmes entering and leaving a clot, as well as developing drug delivery strategies for 
disrupting clot formation or enhancing lysis. 
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ELASTIC BEHAVIOR AND PLATELET RETRACTION IN LOW AND HIGH 
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4.1 Abstract  
Fibrin is a biopolymer that gives thrombi the mechanical strength to withstand the forces 
imparted on them by blood flow. Importantly, fibrin is highly extensible but strain hardens at low 
deformation rates. The density of fibrin in clots, especially arterial clots, is higher than in gels 
made at plasma concentrations of fibrinogen (3−10 mg/mL) where most rheology studies have 
been conducted. The objective of this study is to measure and characterize the elastic regimes of 
low (3−10 mg/mL) and high (30−100 mg/mL) density fibrin gels using shear and extensional 
rheology. Confocal microscopy of the gels shows that fiber density increases with fibrinogen 
concentration. At low strains fibrin gels act as thermal networks independent of fibrinogen 
concentration. Within the low strain regime, the mesh size of fibrin gels can be predicted by the 
elastic modulus using semiflexible polymer theory. Significantly, this provides a link between 
gel mechanics and interstitial fluid flow. At moderate strains, we find that low density fibrin gels 
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act as non-affine mechanical networks and transition to affine mechanical networks with 
increasing strains within the moderate regime, while high density fibrin gels only act as affine 
mechanical networks. At high strains, the backbone of individual fibrin fibers stretch for all 
fibrin gels. Platelets can retract low density gels by greater than 80% their initial volumes, but 
retraction is attenuated in high density fibrin gels and with decreasing platelet density. Taken 
together, these results show that the nature of deformation of fibrin is a strong function of fibrin 
fiber density, which has ramifications for the growth, embolization and lysis of thrombi.  
4.2 Introduction 
Fibrin is one of the most extensively studied biopolymers in terms of rheological 
properties at both the single fiber and network scales (14, 15, 22-25, 29, 81, 85, 129, 130). Fibrin 
is extraordinarily extensible and has nonlinear rheological behavior such as strain hardening and 
negative normal stresses under shear strain (14, 15, 22-26, 29, 81, 85, 129-132). Most reports of 
fibrin gel rheology have been conducted on gels derived from fibrinogen concentrations at or 
near that of human plasma (~3 mg/mL) (14, 22, 29, 133-135). These low density (fibers/volume) 
fibrin gels have fiber volume fractions of less than 5%. Yet, thrombi formed in vivo, fibrin glues 
used for surgical wounds, and tissue engineering matrices can have fiber volume fractions of 
10−50% (31, 32, 136, 137). The objective of this study is to measure the rheology of high 
density fibrin gels, defined as those derived from greater than 10 mg/mL fibrinogen, and to relate 
the mechanics of these gels to their network structure.  
Thrombi formed under flow contain a higher density of fibrin than gels formed under 
static conditions at plasma concentrations of fibrinogen. For example, thrombi retrieved from 
patients with myocardial infarctions have a solid volume fraction of fibrin fibers of ~0.5 (31). 
This high density appears partially due to the effect of blood flow on fibrin deposition. Fibrin 
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gels formed under flow on procoagulant surfaces have fibrin density that are five-fold higher 
than gels formed at 3 mg/mL fibrinogen (32). Platelet retraction can reduce the volume of low 
density fibrin gels (2 mg/mL fibrinogen) by as much as 90%, thereby yielding a much denser 
network of fibers (138). The magnitude of platelet contractile forces imparted on a substrate 
increases with increasing stiffness of the substrate (139), however the ability of platelets to 
retract high density fibrin gels is unknown. Thus, the rheology of high density fibrin gels is 
important because it will determine, in part, whether the stresses imparted by blood flow will 
cause the clot to deform reversibly or irreversibly, or to embolize as well as the degree of 
platelet-mediated retraction.  
In addition to its role in mechanics, the density of fibrin partly determines the fluid and 
solute transport into and out of a thrombus. In vitro (68), in vivo (58) and computational (34, 50, 
56) studies suggest that the hindered transport of coagulation enzymes and platelet agonists in 
the interstitial space between platelets and fibrin fibers is a mechanism that contributes to 
thrombus arrest. Specifically the transport of coagulation enzymes from the injured vessel wall 
through the porous clot may regulate the late stages of clot growth (51). Moreover, the transport 
of fibrinolytic agents like tissue plasminogen activator into a thrombus regulates the rate of its 
dissolution (20). Measuring transport properties such as hydraulic permeability and diffusion 
coefficients in vivo is difficult compared to mechanical properties, which can be estimated by 
ultrasound and other imaging modalities (140). As such, providing a link between thrombi 
mechanics and transport should prove useful in developing therapeutic approaches for 
thrombosis.  
Low density fibrin gels have a strain dependent rheology characterized by several elastic 
regimes. These regimes are categorized as networks undergoing either entropic, thermal 
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fluctuations or enthalpic, mechanical deformation. Mechanical deformation is further divided 
into affine and non-affine models. Affine models assume that fibers deform such that the strain 
of individual fibers is identical to the macroscopic strain; a Poisson’s ratio of one-half (i.e. 
incompressibility) is also assumed. Non-affine models account for deviations at the microscopic 
scale from the affine assumption (141). Nonlinearity in non-affine networks originates from 
network reorganization that leads to a transition from fiber bending/buckling to fiber stretching 
(84). For sufficiently large strains, fiber buckling may even lead to a decrease in shear modulus 
(141, 142). At low strains, low density fibrin gels have been shown behave as networks of 
semiflexible polymers where the elasticity is dominated by thermal fluctuations and entropic 
resistance to stretching; however, at high strains the nonlinear response of fibrin deviates from 
the entropic model (28). At higher strains low density fibrin gels undergo non-affine deformation 
(141, 143) and exhibit Poisson ratios above the incompressible value of 0.5 (i.e., they lose mass 
upon deformation) (135, 144). 
In this report, we use shear and extensional rheology and platelet retraction to 
characterize the mechanical properties of low and high density fibrin gels (3–100 mg/ml) and 
determine how these properties relate to network structure. All gels act as thermal, affine 
networks at low strains. This allows for predictions of mesh size from elastic modulus, and thus 
provides a link between mechanics and fluid and solute transport. Non-affine behavior is 
apparent in low, but not high, density fibrin gels at moderate strains. Platelets retraction of fibrin 
gels is attenuated with increasing fibrin density.  
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4.3 Experimental Methods 
Fibrin gels were made with at a range of fibrin concentrations and tested using both shear 
and extensional rheology over a range of strains. Platelet retraction was tested at physiological 
and low platelet counts 
4.3.1 Materials 
Human fibrinogen (free of plasminogen, von Willebrand factor and fibronectin) in 
20 mM sodium citrate and human α-thrombin was purchased from Enzyme Research 
Laboratories (South Bend, IN). Factor XIII is present in the fibrinogen solution (145). Centrifuge 
filtration units with a 100 kDa molecular weight cut off were from Millipore Corp (Billerica, 
MA). Prostacylin (PGI2) was from Cayman Chemicals (Ann Arbor, MI). #88 T316 stainless 
steel mesh with 200µm openings was from TWP Inc. (Berkeley, CA). 10% (by weight) sodium 
dodecyl sulphate (SDS) solution, 40%Acrylamide (19:1 Acrylamide:Bis-acrylamide) solution, 
Ammonium persulphate (APS), tetramethylethylenediamine (TEMED), 2-mercaptoethanol 
(βME), 10x premixed electrophoresis buffer (containing 25 mM Tris, 192 mM glycine, pH 8.3), 
4x Laemmli protein sample (containing 277.8 mM Tris-HCl, pH 6.8, 4.4% LDS, 44.4% (w/v) 
glycerol, 0.02% bromophenol blue), Tris base, Precision Plus Protein™ Kaleidoscope™ 
Standards (10-250 kDa) and Bio-safe Coomassie Blue stain were all purchased from Bio-Rad 
(Hercules, CA). Tris buffer was prepared by dissolving 1.5 M Tris base in deionized water and 
pH 8.8. All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO). Tris buffered 
saline (TBS; 50 mM tris base, 100 mM NaCl, pH 7.4), modified Tyrode’s buffer (129 mM NaCl, 
20 mM HEPES, 12 mM NaHCO3 2.9 mM KCl, 1 mM MgCl2, 0.34 mM Na2HPO4#12H20, pH 
7.3), acid-citrate dextrose (ACD; 0.085 M sodium citrate 0.085 M, 0.11 M D-glucose, 0.071 M 
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citric acid monohydrate), and sodium citrate solutions (0.13 M, pH 9.1) were made in house. 
AlexaFluor 555 labeling kit was purchased from Life Technologies (Grand Island, NY). 
4.3.2 Preparation of fibrin gels 
Fibrinogen stock solutions were prepared as previously described (146). Briefly, 
fibrinogen stock solutions (12.9 mg/mL) were centrifuged at 4000 g at 37 °C for 2 h in filtration 
units. After centrifugation the retentate was removed from the device and diluted in TBS. The 
concentration of fibrinogen in the retentate was determined by using a modified Clauss assay to 
measure the concentration of a known dilution of retentate to achieve a ~1 mg/mL fibrinogen 
solution (see Appendix B.1); 10 nM thrombin and 2.5 mM CaCl2 were added to 100X diluted 
retentate in a 96 well plate (200 µL final volume) (98, 147). After 20 min, the absorbance was 
measured in a plate reader (Victor X, PerkinElmer) and the concentration was determined from a 
standard curve. Both the concentrated fibrinogen stock solution and fibrinogen in sodium citrate 
were tested for the presence of aggregates by dynamic light scattering with a size range of 
1 nm−10 µm (Zeta PALS, Brookhaven Instruments, Holtsville, NY). Fibrinogen solutions of 3, 
10, 30, 50, and 100 mg/ml in TBS were mixed with 2.5 mM CaCl2 (final concentration) and 10 
or 100 nM thrombin (final concentration).  
To determine the extent of conversion of fibrinogen to fibrin gels a test was conducted in 
which gels were allowed to form for 50 min after which excess buffer was added to the gels to 
capture any unincorporated fibrinogen for testing. Fibrin gels (0.5 mL) identical to those used for 
rheological testing were formed in 24-well plates for 50 min. After gelation, an additional 
0.5 mL of TBS was pipetted onto the top of each gel. The gel-TBS mixtures were homogenized 
with a glass rod and incubated for 24 h to allow any unincorporated fibrinogen to diffuse out of 
the formed gel and into the TBS. After incubation the visible particles of the broken clot were 
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removed from the disrupted gel-TBS mixture by filtering the mixture through a screen with 
200 µm × 200 µm pores. The remaining filtrate was tested for the presence of unreacted 
fibrinogen by polymerizing any unreacted fibrinogen present in the filtrate; CaCl2 (2.5 mM) and 
thrombin (10 nM) were added to the filtrate to induce gelation and the modified Clauss assay 
(Appendix B.1) was used to determine the concentration of the fibrin in the gel.  
4.3.3 Small strain dynamic shear rheology 
Shear and normal stresses were measured with a DHR-3 rheometer from TA Instruments 
(New Castle, DE) using a parallel plate (d = 20 mm, stainless steel) and solvent trap to prevent 
evaporation. Recalcified fibrinogen (161.5 µL) was pipetted on the bottom plate. Thrombin 
(8.5 µL) was added to the fibrinogen solution and the top plate was quickly (~3 s) lowered to a 
gap height of 500 µm while being spun freely at approximately 60 RPM to induce mixing. Each 
sample was subjected to four tests: (1) shear storage (G’) and loss (G’’) moduli were measured at 
1% strain and at 1Hz for 3000 s to monitor gelation. Samples were assumed to have reached their 
steady state if G’ did not change by greater than ±5% over the time period of 2700−3000 s; (2) 
an oscillation sweep with strains of 0.01−1% at 1 Hz; (3) a frequency sweep from 0.01−3 Hz at 
1% strain; (4) shear storage (G’) and loss (G’’) moduli were again measured at 1% strain and at 
1Hz but for 300 s to detect changes greater than ±10% in the gel induced by (2) or (3). If changes 
greater than ±10% occurred the sample was discarded. 
4.3.4 Shear and normal stresses under a strain ramp 
Using an identical sample preparation and gelation test (step 1 above), the gel was 
deformed at a strain rate of 0.01 s−1 until each sample broke. The shear and normal stresses and 
the shear modulus (G) were recorded (79). 
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4.3.5 Extensional rheology 
Glass slides (50 mm × 75 mm) were coated with 25% Triton X-100 in TBS to prevent 
fibrin from adhering to the glass. Fibrin gels (30, 50 and 100 mg/ml) were formed between two 
glass slides separated by a 450 µm (l = 50 mm, w = 10 mm, thickness = 0.45 mm) polypropylene 
spacer; 10 mg/ml fibrin gels were formed between two glass slides separated by three 450 µm 
spacers stacked on each other (total thickness = 1.35 mm). A thicker sample was needed for the 
low fibrinogen concentration to allow for handling without deforming the sample. Sample 
thickness varied by less than 1% across the sample. Gels were allowed to form in a humidified 
chamber for 50 min. Gel samples (l = 20 mm and w = 3−6 mm) were cut from each casting with 
a razor blade for tensile testing on a ARES-G2 rheometer (TA Instruments, New Castle, DE) 
with the Sentmanat Extensional Rheometer (SER) fixture (148) with rough textured drums. 
Samples were stretched at 10 mm/min (135). Elastic modulus, E(γ), defined as slope of the 
stress-strain curve at each value of γ was determined by fitting a fifth degree polynomial to the 
stress-strain data using the Matlab function polyfit and then taking the first derivative of the 
polynomial (Fig. B.1).  
4.3.6 Platelet retraction of fibrin gels 
Platelet mediated retraction of fibrin gels was performed using a modified version of 
previously reported protocols (149). Non-silicanized glass vials (Alltech Associates, Deerfield 
IL) were incubated with 5 mg/ml BSA in modified Tyrode’s buffer for 1 h at room temperature, 
rinsed with deionized water and dried with an air brush. Whole blood was collected by 
venipuncture into a syringe containing 3.8% sodium citrate. The first 5 mL of blood was 
discarded. ACD was then added to the blood in a 1:10 ratio. The anticoagulated blood was 
centrifuged at 200g for 20 min. Then supernatant platelet rich plasma (PRP) was removed, and 
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PGI2 (1.3 µM) was added to inhibit platelet activation. The PRP was centrifuged at 1000g for 10 
min and the platelet poor plasma (PPP) was decanted off the platelet plug, which was 
immediately resuspended in modified Tyrode’s buffer. After repeating the same wash step the 
resuspended platelets were enumerated (Z1 Coulter Counter, Beckman Coulter, Brea, CA). 
Platelets concentrations of in 500 µL of 3, 10, and 30 mg/mL 2×104 and 2×105 platelets/µL 
fibrinogen were placed in glass vials followed by the addition of MgCl2 and CaCl2 at 3.75 mM 
and 7.5 mM, respectively. Finally, clotting was induced with 10 nM α-thrombin. Clots retraction 
was recorded for 5 h at 37 °C. Following retraction the entire system (clot + liquid + glass) was 
weighed. Next, the retracted clot was removed and the remaining liquid and glass were weighed. 
Finally, the mass of the dried glass vial was measured and the volume of the expelled liquid was 
calculated assuming a liquid density of 1.01 mg/ml. The percent retraction is reported as the 









'  (4.1) 
where PR is percent retraction, Vtot, is the total clot volume, mg+l is the mass of the glass vial plus 
the liquid, mg is the mass of the glass vial, and ρl is the density of the liquid. The calculated mass 
of the clot, (mc+g+l – mg+l) was used to confirm the total mass of the system did not change over 
the course the experiment. 
4.4 Theory 
The following theoretical models of fibrous networks are used to interpret bulk rheology 
experimental data in the context of single fiber mechanics and network structure.  
4.4.1 Calculation of Mesh Size 
The mesh size, ξ, of fibrin gels was determined by measuring the hydraulic permeability, 
k, by previously reported methods (146):  
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 (4.2) 
The square root of the permeability is a hydrodynamic screening length for flow through fibrous 
media that is used to estimate the distance between fibers in hydrogels (62, 150). 
4.4.2 Predicting mesh size from elasticity of thermal affine networks 
The shear modulus (G) of a thermal affine elastic network can be connected to mesh size 
of the network by: 
 (4.3) 
where κB is the bending modulus of a fibrin fiber (see Supporting Material for calculation), kB is 
Boltzmann’s constant, T is the absolute temperature, and Lc is the length of a fiber in the network 
(151). The length of each fiber was taken to be 2 µm, within the range (2.86 ± 2.51 µm) as 
measured by Kim et al. (152). Ryan et al. reported that the fiber length was roughly independent 
of fibrinogen concentration from 0.5−6 mg/mL (153). The bending modulus, κB, was estimated 
to be 4.5 × 10−24 N m2 by assuming the fibrin fibers are bundles of coupled protofibrils (154) 
with each protofibril having a persistence length of 500 nm (81) (see Appendix B.5.2 for 
calculation).  
4.4.3 Using negative normal stresses to categorize fibrin gels at moderate strain 
Fibrin’s nonlinear elastic response has been described by two models: (1) The thermal 
network model that considers the gel fibers to have nonlinear force-elongations that arise from 
thermal fluctuations (155) and (2) the mechanical network model that considers the gel fibers to 
be mechanical rods with linear force-elongation relations where nonlinearity arises from 







The ratio of the negative first normal stress to shear stress (−σN/σS) as a function of strain 
can distinguish between the two models. Both models show a small-strain regime characterized 
by σN ≈ γS2 and σS ≈ γS, where γS is the shear strain. The range of strains that the small-strain 
regime scaling holds increases with increasing fiber density (number of fibers per unit volume) 
for the mechanical network model whereas in the thermal network the range decreases with 
increasing fiber density (26, 156). Accordingly, if the small-strain regime increases with 
increasing fiber density, the thermal network model is supported whereas if it decreases, the 
mechanical model is more appropriate. Additionally, within the mechanical model, a peak where 
the normal stresses exceed the shear stresses at small strains is indicative of fibers that are softer 
to bending rather than stretching (156). This behavior where the ratio of normal stress to shear 
stress is greater than unity is inconsistent with a purely thermal model (79). 
4.4.4 Distinguishing non-affine and affine mechanical networks  
Mechanical networks can be categorized as nonaffine or affine, depending upon their 
bending (κB) and stretching (µ) moduli and fiber length (80, 157, 158). A distinguishing feature 
of these networks is the relationship between the shear modulus (G) and the elastic modulus (E). 
Purely affine networks are dominated by stretching modes, have a Poisson’s ratio (ν=E/2G-1) of 
0.5 (80) and are described by:  
 (4.4) 
Nonaffine networks have elastic regimes dominated by bending modes and show deviations from 
Eq. 4.4 as predicted by elasticity theory (159). The transition from affine to nonaffine 
deformation is shown in a depression of G (159, 160). As the affine linear modulus serves as the 
upper bound for G at moderate strains, a depression in G results in an increased ratio of E/G for 
increasingly non-affine networks. These high values of E/G, by definition, result in an elevated 
ΕAffine = 3GAffine
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Poisson’s ratio (ν > 0.5). Thus, volume is not conserved but rather decreases upon stretching, a 
phenomenea observed in fibrin gels as mass loss during extensional strain (135, 144). 
4.5 Results  
The elasticity of fibrin gels was found to be a strong function of fibrin concentration and 
strain. Fibrin gels transition from a thermal network regime to a nonaffine mechanical to an 
affine mechanical regime or directly from a thermal network to an affine mechanical regime 
depending upon fibrin concentration 
4.5.1 Verification of fibrinogen conversion to fibrin 
Fibrin gels were formed from 3, 10, 30, 50 and 100 mg/mL fibrinogen and 10 and 100 nM 
thrombin. The density of fibers increases with increasing fibrinogen concentration (Fig. 4.1). A 
stock solution of fibrinogen (12.9 mg/mL) was concentrated by centrifugation to 
130−160 mg/mL. Absorbance measurements at 450 nm showed that the fibrinogen in the 
concentrated retentate remained soluble at room temperature (Appendix B.2 & Fig. B.2). This 
concentrated solution was found to contain no aggregates as measured by dynamic light 
scattering. The measured particle diameter of the concentrated fibrinogen solution was 30 nm 
with a dispersity of 0.2, identical to the values reported by the vendor. All fibrinogen appeared to 
be converted to fibrin. No fibrinogen was present in the excess TBS; the excess TBS solution did 
not form a gel but remained liquid upon testing the extent of reaction and no excess fibrinogen 
was detected by the modified Clauss assay. Factor XIII is present in the stock fibrinogen 
solution. SDS-PAGE analysis showed that 3−50 mg/mL fibrinogen gels were completely cross-
linked as indicated by the absence of γ monomers and presence of γ dimers (Fig. B.3). 
100 mg/mL fibrinogen gels were partially cross-linked as both γ monomers and dimers were 
present. 
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4.5.2 Fibrin gels are linearly viscoelastic for all fibrinogen concentration at low strains 
After monitoring gelation with step 1 for 3000 s (Fig. B.4), amplitude sweeps over strains 
of 0.01% to 1% at 1 Hz were conducted to confirm linear viscoelastic behavior. There was less 
than 5% change in G’ and G’’ for all gels over this range of strains suggesting linear viscoelastic 
behavior. At a strain of 1%, gelation was confirmed by a plateau in G’ during low frequency  
sweeps (0.01 Hz to 3 Hz) and linear viscoelasticity (Fig. 4.2) (161). G’ was roughly independent 
of frequency at all fibrinogen concentrations indicating the absence of relaxation mechanisms at 
these frequencies for a strain of 1%. G’ was more strongly dependent on fibrinogen 
concentration than thrombin concentration. G’’ showed a modest increase with increasing 
frequency at all fibrinogen concentrations, indicating a relaxation mechanism whose reciprocal 
time constant exists above the experimental range of the frequencies measured. This trend 
suggests that fibrin acts as a viscous liquid only on long time scales. For all gels tested the  
 
Figure 4.1. Laser scanning confocal microscopy images of fibrin gels derived from (A) 3 mg/ml, 





Figure 4.2. Dynamic shear rheology of fibrin gels at small strains. G’ (filled symbols) and G” 
(open symbols) of fibrin gels formed at fibrinogen concentrations of (q) 3 mg/ml, (p)10 mg/ml, 
(n) 30 mg/ml, (u) 50 mg/ml, and (l) 100 mg/ml as a function of frequency at a strain of 0.01. 
Gels formed with 10 nM (A) and 100 nM (B) thrombin. Data is presented as the mean and 
standard deviation (n=3).  
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dynamic shear storage modulus dominated the mechanical response; gels showed tan δ (G”/G’) 
values of 0.05±0.01 independent of fibrinogen or thrombin concentrations. G’ and G’’ increased 
rapidly with fibrinogen concentration of 3−30 mg/mL, and were less sensitive from 
30−100 mg/mL (Table 4.1).  
4.5.3 Strain hardening under shear is attenuated in high density fibrin gels 
The shear modulus (G) of fibrin gels formed with 10 nM thrombin was measured as a function of 
strain during a constantly increasing deformation test at a strain rate of 0.01 s−1 over strains of 
10−3 to 1 (Fig. 4.3). At low strains (γ = 10−3) the G value was similar to the measured dynamic 
storage modulus (G’) value. This is expected as G’ was frequency independent and much greater 
than G’’ for all gels. G ranged from approximately 100−20,000 Pa as fibrinogen concentration 
was increased from 3−100 mg/ml, with most of the change occurring over the range of 
3−30 mg/ml. Given the viscoelastic nature of the gels, it should be recognized that the strain 
hardening is expected to be ramp rate dependent. At the selected ramp rate, low density fibrin 
gels (3, 10 mg/mL) showed significantly greater strain hardening than high density fibrin gels 
(30, 50, 100 mg/mL) at strains of 0.1−1. Fibrin gels formed at 3 and 10 mg/ml had roughly one 
order-of-magnitude increase in G for γ > 0.05. Gels formed at 30−100 mg/ml either remained 
Table 4.1. Dynamic shear storage (G’) and loss (G’’) moduli of fibrin gels at small strains. Data 





G’ at 1 Hz  [Pa] 
(SD) 
G’’ at 1 Hz  [Pa] 
(SD) 
10 3 158 (60) 5.6 (2.8) 
10 10 964 (380) 75 (15) 
10 30 8200 (1000) 4800 (130) 
10 50 12,800 (5300) 700 (51) 
10 100 16,500 (7700) 784 (173) 
100 3 110 (16) 4.7 (0.6) 
100 10 840 (65) 56 (3.0) 
100 30 8200 (420) 320 (30) 
100 50 19,100 (3100) 800 (100) 
100 100 26,200 (3900) 1700 (367) 
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relatively constant at moderate strains or showed a very slight degree of strain softening below 
strains of 0.2 and a modest degree of strain hardening at higher strains.  
4.5.4 Extensional rheology reveals two strain hardening regimes 
Similar to shear rheology, the stress-strain relationship in biaxial extension of fibrin gels 
was weakly dependent on thrombin concentration compared to fibrinogen concentration 
(Table 4.2, Fig. 4.4 A and B). Note that 3 mg/mL gels were not tested because they were unable 
to support their own weight in the SER fixture. Stress-strain curves of all gels 10 mg/ml and 
greater showed two regions of strain hardening (Fig. 4.4 C and D). The first region occurred at 
strains of 0.01 < γ < 0.25. This is similar to the strain hardening seen under shear stress in 
Fig. 4.3. The second region occurred at strains of γ  > 0.75. At strains of 0.25 < γ < 0.75, E(γ) 
 
Figure 4.3. Strain hardening in low and high density fibrin gels. The shear moduli, G, of fibrin 
gels formed with 10 nM thrombin and 3 (green), 10 (magenta), 30 (blue), 50 (red), and 100 
mg/ml (black) fibrinogen as a function of strain. The shaded region represents the standard 
deviation (n=3). Note that the 50 and 100 mg/ml lines overlap such that it is difficult to 
discriminate them from each other; the gray shading corresponds to the standard deviation of the 




Figure 4.4. Biaxial extensional stress-strain data for fibrin gels formed with 100 nM (A) and 10 
nM (B) thrombin and 10 (magenta), 30 (blue), 50 (red), and 100 mg/ml (black) fibronogen. The 
shaded region represents the standard deviation (n=5-8). The corresponding elastic moduli were 
found by taking the first derivative of a fifth order polynomial fit to the stress-strain data for gels 
formed with 100 nM (C) and 10 nM thrombin (D). 
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10 10 0.9 3.4 23 6.7 5.1 (4.0) 1.0 (0.39) 
10 30 6.3 8.9 20 2.3 19 (4.3) 1.4 (0.17) 
10 50 5.8 13.7 60 4.4 33 (10) 1.4 (0.22) 
10 100 5.5 16.4 110 6.9 36 (8.2) 1.3 (0.09) 
100 10 2.1 3.0 15 5.0 3.9 (1.4) 1.0 (0.09) 
100 30 6.0 10.9 39 3.6 25 (6.3) 1.4 (0.18) 
100 50 8.3 11.5 66 5.7 27 (10) 1.4 (0.21) 
100 100 12.7 20.1 120 5.9 39 (6.8) 1.2 (0.07) 
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remained relatively constant. The stress at break increased from 3.2 × 104 Pa to 39 × 104 Pa with 
increasing fibrinogen concentration. The strain at break was 1.0−1.6 for all gels, with no 
apparent trend for different fibrinogen concentrations. For reasons discussed below, the first 
strain hardening regime is likely caused by network rearrangement, and the second regime is 
likely caused by fiber stretching. 
4.5.5 High density fibrin gels act as thermal affine networks at small strains based on 
mesh size scaling 
The shear modulus (G) of thermal affine networks scales with mesh size according to 
Eq. 4.3. The mesh size of fibrin networks was independently estimated by Eq. 4.2 using 
measurements of hydraulic permeability (146) and by Eq. 4.3 using the measured G values at 
low strains (γ = 0.01) for fibrin gels formed with 10 nM and 100 nM thrombin. There is good 
agreement between estimates of mesh size based on permeability and G (Fig. 4.5 A and B). The 
predicted mesh size ranges from 300−400 nm in 3 mg/ml gels to 20−30 nm for 100 mg/mL gels. 
The largest change in mesh size occurred over the range of 3−30 mg/ml fibrinogen. There was 
only a modest change in mesh size at higher fibrinogen concentrations. 
4.5.6 Negative normal stresses show that fibrin gels act as mechanical networks at 
moderate strains 
The ratio between negative normal stress and shear stress (-σN/σS) at strains greater than 0.01 is 
characteristic of a network of mechanical elastic rods for all fibrinogen concentrations 
(Fig. 4.6 A–E). The -σN/σS ratio shows an initial large increase with strain before reaching 
maximums between strains of 0.15−0.25, and then decreasing at higher strains. All gels showed a 
small strain regime with scaling of σN ≈ γS2 and σS ≈ γS. This scaling held for larger strains with 




Figure 4.5. Mesh Size, ξ, of fibrin gels formed with (A) 10 nM thrombin and (B) 100 nM 
thombin as calculated by measurements of G’, Eq. 4.3 (white bars) and permeability, Eq. 4.2 
(black bars) for fibrin gels formed with 3 – 100 mg/ml fibrinogen. 













































of the –σN/σS curve and reduced peak with increasing fibrinogen concentrations suggests that that 
gels with higher fiber density are more susceptible to fiber stretching relative to bending; a 
feature than might be expected as mesh size decreases and the length between strand supporting 
junctions decreases. These features are consistent with models of mechanical networks that 
predict fibers become less susceptible to bending as the maximum of the curve becomes smaller 
(79, 156).  
4.5.7 Affine and non-affine mechanical networks as a function of fibrin density  
The ratio of elastic modulus to shear modulus, E(γ)/G(γ), can be used to characterize 
affine and non-affine mechanical deformation. Using data from shear and extensional rheology 
(Figs. 4.3 and 4.4), the ratio of the material functions E(γ)/G(γ) as a function of strain was 
 
Figure 4.6. Negative normal stress to shear stress ratio plotted verses strain for fibrin gels 
formed with 10 nM thrombin and (A) 3 mg/ml, (B) 10 mg/ml, (C) 30 mg/ml, (D) 50 mg/ml, and 
(E) 100 mg/ml fibrinogen. 
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compared for 10−100 mg/ml gels (Fig. 4.7). At low strain (γ < 0.003), E(γ)/G(γ) was ~3, which is 
the affine prediction (Eq. 4.4). As strain was increased, E(γ)/G(γ) of all gels increased, reaching 
local maximums at strains of 0.1−0.3 with the strain at maximum increasing with increasing 
fibrinogen concentration. As strain was further increased, E(γ)/G(γ) of all gels decreased to local 
minimums at strains of 0.6−0.7. Finally, the E(γ)/G(γ) ratio of all gels increased again as strain 
was further increased above 0.7. The E(γ)/G(γ) ratio of the 10 mg/ml gel reached a maximum 
value of 48 at a strain of 0.15 before decreasing to a local minimum of 19 at a strain of 0.6. The 
E(γ)/G(γ) ratio of the 30, 50, and 100 mg/ml gels were less sensitive to strain, all reaching local 
maxima of approximately 10 at strains of 0.2, 0.25, and 0.3, before decreasing to values 
of 3, 5, and 9 at strains of 0.7, 0.65, and 0.6, respectively. The decrease in E(γ)/G(γ) toward the 
affine limit as strain is increased from 0.15 to 0.6 indicates that fibrin gels become more affine 
with increasing strain.  
 
Figure 4.7. The ratio of elastic moduli, E(γ), to shear moduli, G(γ), of fibrin gels formed with 
10 nM thrombin and 10 (magenta), 30 (blue), 50 (red), and 100 mg/ml fibrinogen (black) as a 
function of strain. The error bars represent the propagated error (shear n=3, extensional n = 5-8). 
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4.5.8 Platelet retraction of fibrin gels depends on both platelet and fibrin density  
Fibrin gels derived from 3, 10, and 30 mg/ml fibrinogen and 10 nM thrombin were 
created with the inclusion of 2 × 104 and 2 × 105 platelets/µL and allowed to retract for 5 h at 
37°C. The majority of the retraction occured in the first hour and there was little change in gel 
volumes after two hours (Appendix C, Retraction Movie). Gels formed with 2 × 105 platelets/µL 
showed final retraction values 97.5% ± 0.1%,  89.3% ± 1.0%,  39.0% ± 2.9% for 3, 10, and 
30 mg/ml gels, respectively (Fig. 4.8). Gels formed with 3 and 10 mg/ml fibrinogen and 
2 × 104 platelets/µL retracted by 75.1% ± 10.5% and 23.4% ± 0.8%, respectively (Fig. 4.8). The 
was no measureable retraction for gels formed with 30 mg/ml fibrinogen and 
2 × 104 platelets/µL. Due to the reduction in clot volume resulting from retraction, gels formed 
with 2 × 105 platelets/µL resulted in gels with final fibrin concentrations of 119 ± 0.1 mg/ml, 
 
Figure 4.8. Percent retraction of fibrin-platelet gels formed with (white bars) 2×105 platelets/µL 
and  (black bars) for fibrin gels formed with 3−30 mg/ml fibrinogen. Data 2×104 platelets/µL
represents the mean and standard deviation (n=3). 

















93 ± 1.1 mg/ml, 49 ± 3.7 mg/ml for gels with initial concentrations of 3, 10, and 30 mg/ml, 
respectively. Gels formed with 2 × 104 platelets/µL resulted in clots with fibrin concentrations of 
12 ± 1.7 mg/ml and 13 ± 0.5 mg/ml for gels with initial concentrations of 3 and 10 mg/ml, 
respectively. The degree of retraction could be slighly overestimated due to collapse fibrin gels 
during removal from the tube. The contractile force of a platelet is 4 nN on a substrate with 
10 kPa, which is comparable to the elasticity of a 30 mg/ml gel (Fig. 4.2) (139). elasticity of ~
Using this force, we estimated that a platelet could bend a fibrin fiber 2 nm and stretch a fiber 
64 nm in a 30 mg/ml gel (see Appendix B.5.3 for calculation). The same force could bend a fiber 
770 nm and stretch a fiber 64 nm in a 3 mg/mL gel. Although these calculations assume that 
fiber bending and stretching moduli are independent of fiber density, they do suggest a trend 
where platelet-mediated retraction in high density fibrin gels may be limited to fiber stretching, 
which is consistent with affine deformation.  
4.5.9 Fibrin rheology state diagram 
Results from shear and extensional rheology experiments show that low and high density 
fibrin gels are characterized by strain dependent network rearrangement and fiber stretching 
regimes. Fig. 4.9 shows a proposed state diagram of these different regimes. The evidence 
supporting this state diagram is summarized below. 
At low strains (γ < 0.01), all fibrin gels exhibit an initial linear regime where elasticity is 
determined by thermal fluctuations of the fibrin fibers that undergo affine deformation regardless 
of fiber density. Fibrin elasticity in this low-strain linear regime is well described by the thermal 
affine model, Eq. 4.3; the mesh size for fibrin gels as measured by elasticity and permeability 
show good agreement over the entire range of concentrations tested. Furthermore, the E/G ratio 
is close to the affine limit for all gels at low strains. These results are in agreement with previous 
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measurements of low density fibrin gels at low strains (28). Here, we find that this model also 
holds for high density fibrin gels. At increasing strain, we find that all fibrin gels transition away 
from the linear regime at γ ~ 0.01 as indicated by the deviation of E(γ)/G(γ) from the affine 
predictions (Fig. 4.7). This agrees with the results of Piechocka and colleagues who found that 
the ‘thermal slack’ is pulled out of fibrin fiber at strains of 0.01 for fibrin gels formed with 
between 3 – 8 mg/ml fibrinogen (28). 
At moderate strains (0.01 < γ < 0.6) elasticity is determined by mechanical network 
deformations. The scaling in the small strain regime where σN ≈  γS2 and σS ≈  γS with fibrinogen 
concentration and the shape of the -σN/σS curve where the values of the ratio trends toward 0.5 
with increasing strain with a possible peak at lower strains are characteristics of mechanical 
 
Figure 4.9. Proposed state diagram of the elastic regime of fibrin gels as a function of fibrinogen 
concentration and strain. At strains of less than a few percent, network elasticity is dominated by 
entropic restrictions of thermally fluctuating fibers (green) for all gel concentrations, this is the 
Affine Thermal (AT) regime. As strain is increased, fibrin gels transition into a regime where 
elasticity is mechanically dominated. High density (HD) gels transition directly to an affine 
mechanical stretching (AMS) regime where fibers are mechanically stretched (blue). Low 
density (LD) gels transition to a non-affine mechanical bending (NMB) regime where bent fibers 
(orange) allow for network rearrangement. Eventually, network rearrangement results in fibers 
that effectively span the network and stretch causing the LD gels to transition into the AMS 
regime. At strains greater than 60-70% the filament backbone of stretched due to protein 
unfolding or other mechanisms, this is the filament backbone stretching (FBS) regime. 
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networks. Whether network deformation is dominated by nonaffine fiber bending or affine fiber 
stretching depends on fiber density and strain.  
Gels formed from 3 and 10 mg/ml fibrinogen appear to first transition into a nonaffine, 
bending-dominated deformation regime before ultimately reaching an affine, stretching-
dominated regime at higher strains. The evidence of nonaffine mechanical bending is the high 
E(γ)/G(γ) ratios indicating a strong deviation from the affine assumption. The peak in the 
E(γ)/G(γ) ratio shows that the maximum nonaffine deformation occurs at a strain of ~0.15 before 
deformations become more affine E(γ)/G(γ) decreasing) as strain is increased to 0.6.  
Furthermore, sharp peaks in the -σN/σS ratios at strains of 0.1−0.2 are characteristic of the 
nonaffine, bending regime (79, 156). Microrheology measurements in low density fibrin gels 
show a peak at non-affine deformation at slighly lower strains (0.02), but show a similar trend 
toward affine deformation at increasing strain (36). At increased strain, the -σN/σS ratio of all gels 
approach the same value of ~ 0.5, indicating a weak dependence on bending and a stretching 
dominated regime (79, 156).  
Gels formed from 30, 50, and 100 mg/ml fibrinogen transition from affine thermal 
fluctuations directly into a predominantly affine, stretching-dominated regime. This conclusion is 
based on E(γ)/G(γ) ratios that deviate only slightly from the affine prediction. High concentration 
gels also show a less pronounced peak in the -σN/σS ratios before decreasing to approach the 
same value of ~ 0.5, indicating more stretching dominated deformations over the entire range of 
strains. Using criteria developed by Broedersz and colleagues, we can estimate the transition 
from non-affine to affine mechanical deformations using the ratio of fiber length (Lc) to critical 
length (λNA) that is a function of mesh size (see Appendix B.5.2). Gels formed with 
30−100 mg/ml fibrinogen have Lc/λNA >> 1 suggesting that the mechanical deformation regime 
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of these gels is stretching dominated and is largely affine (Table 4.3). Gels formed at 3 and 
10 mg/ml fibrinogen have Lc/λNA on the order of unity, suggesting that these gels do not deform 
with purely affine modes, but instead have some degree of nonaffine bending. 
At high strains (γ > 0.6), all fibrin gels again strain harden. We assume that the strain 
hardening in this regime is due to unfolding of fibrin molecules based on previous reports (28, 
29, 133). However, other mechanisms may be simultaneously present. 
 Discussion4.6  
The objective of this study was to measure and characterize the mechanical properties of 
fibrin gels over a range of fibrinogen concentrations that are representative of arterial thrombi, 
fibrin surgical glues and tissue engineering scaffolds. Our results show that fibrin undergoes a 
variety of elastic deformations as a function of strain in agreement with previous reports (27, 81, 
86, 131). Here, we show that there are unique features that distinguish low and high density 
fibrin gels. A notable finding was that low density fibrin gels appear to undergo both affine 
stretching and nonaffine mechanical bending at moderate strains, while high density fibrin gels 
undergo primarily affine mechanical stretching. This difference was also apparent in platelet 
retraction assays; retraction was significantly reduced in high density fibrin gels where fiber 
bending is presumably limited. The network mechanics of high density fibrin gels are only 
Table 4.3. Critical lengths (Lc) and filament length:critical length ratio ( for fibrin gels Lc/λNA ) 







10 3 4000 0.5 
10 10 730 2.7 
10 30 83 24 
10 50 18 110 
10 100 11 190 
100 3 4200 0.5 
100 10 380 5.2 
100 30 140 14 
100 50 18 110 
100 100 21 96 
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weakly dependent on fibrinogen concentration, suggesting that fibrin monomers contribute more 
towards changes in the internal structure of fibers, rather than to the network structure above a 
certain fibrinogen concentration.  
The only previous rheological study of high density fibrin gels that the authors are aware 
of comes from Weigandt and colleagues. They measured the mechanics and structure of high 
density fibrin gels by neutron scattering coupled with shear rheology for fibrin gels derived from 
fibrinogen solutions of 1 to 40 mg/ml (86). Our results from dynamic shear rheology and strain 
ramp in shear deformation are in good agreement with their results. In particular, strain 
hardening at moderate strains was attenuated with increasing fibrinogen concentration. The 
degree of strain softening at strains ~0.1 that they observed for high density fibrin gels was more 
pronounced than our observations. This difference could be explained by the differences in 
solvent (water vs. deuterated water) and the relatively high salt concentration (0.5 M NaCl) used 
in their study.  
The observed trend of a transition from thermal semiflexible fibers to mechanical fibers 
for all fibrin gels is consistent with the observations of by Piechocka et al. (28). They report that 
fibrin gels from 0.06−8 mg/ml fibrinogen have linear mechanics described by thermal 
fluctuations of fibers at very low strains, but that strains of only a few percent are adequate to 
remove any thermal slack from the fibers and to force the fibers to mechanically deform. One 
notable difference is our results suggest that low density fiber gels transition from a bending 
controlled nonaffine regime into a mostly affine stretching dominated regime at higher strains, as 
evident from the ratio of E(γ)/G(γ) with increasing strains. This nonaffine regime is further 
supported by measurements of the negative normal to shear stress ratio as a function of strain and 
the direct observation of nonaffine deformations; Wen and colleagues used fluorescent 
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microscopy to track the displacement of beads embedded in a 2.5 mg/ml fibrin gel to show that 
fibrin gels deform nonaffinely with a sharp increase in nonaffine behavior up to a strain of 0.02 
and then a decrease in nonaffine behavior at higher strains (143). The existence of a nonaffine 
regime caused by the fibers’ susceptibility to bending and buckling and resulting network 
ultracompressibility also explains the observed water loss of gels formed with lower fibrinogen 
concentrations (129). The affine deformations characteristic of high density fibrin gels may 
explain their strain softening due to compressive forces generated on fibers oriented 135° away 
from the horizontal axis during shear being great enough to yield fiber buckling where collapsed 
fibers no longer contribute to elasticity (84, 142). Moreover, the absence of a transition from 
bending to stretching likely reduces strain hardening at moderate strains (84).  
Differences between nonaffine bending dominated elasticity in low density fibrin gels to 
affine stretching dominated elasticity in high density fibrin gels may have physiological 
significance in the volume and stability of thrombi formed in vivo. In particular, it appears that 
degree of platelet contraction depends on fiber density. The contractile force of an individual 
platelet increases with increasing substrate stiffness, suggesting that a platelet will pull on higher 
density fibrin gels with a force of up to ~79 nN (139). Despite this increased force, clot retraction 
was still attenuated in high concentration fibrin gels, presumably due to the affine stretching 
dominated deformation of the higher concentration gel. Platelets at concentrations representative 
of those found in blood were able to retract low density fibrin gels by over 90%, in agreement 
with previous reports (138). However, platelets were only able to retract a high density fibrin gel 
by 40%. Retraction of low density fibrin gels could be due to the ability of platelets to induce 
nonaffine, bending deformations of fibers and fiber rearrangement. Based on the estimated 
bending modulus and using the mesh size as a characteristic length, the force generated by a 
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single platelet is sufficient to cause bending deformations of almost a micrometer in 3 mg/ml 
gels, but only negligible bending deformation relative to stretching deformation in 30 mg/ml 
gels. A complementary or alternative explanation is that at mesh sizes of <100 nm it may be 
difficult for platelet to extend filopodia into the dense fibrous network during the retraction 
assays. These observations may be most relevant in venous thrombi that contain high solids 
fractions of fibrin and low solids fractions of platelets. It is possible that the increased platelet 
density associated with flow-formed arterial clots might produce sufficient force to retract even 
the most highly concentrated fibrin gels.  
The physical properties of low and high density fibrin gels show a significant difference 
in the dependence on fibrinogen concentration. Both interstitial fluid flow, as measured by 
permeability, and elasticity, as measured by shear and extensional rheology, show a strong 
dependence on fibrinogen concentrations over the range of 3−30 mg/ml. At higher 
concentrations, the changes in these properties are modest up to 100 mg/ml. The strong 
dependence of elasticity on fibrinogen concentration at low fibrinogen concentrations can be 
attributed to the change in mesh size, and thus fiber density as previously reported (146, 153). 
This relationship is also evident in confocal microscopy images of low and high density fibrin 
gels. The weak dependence at higher fibrinogen concentrations suggests that the excess 
fibrin(ogen) may be leading to denser fibers. This reasoning is supported by neutron scattering 
studies that show solid volume fraction within fibers scales with increasing fibrinogen 
concentration (86). We hypothesize these denser fibers have different mechanical properties at 
high strains, although there are no single fiber measurements to date to support this hypothesis.  
Regardless of fiber density, fibrin gels act as thermal affine networks at low strains. Here, 
we used this feature in combination with semiflexible polymer theory to estimate mesh size from 
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elasticity measurements. We found good agreement between mesh size as measured by two 
independent methods (permeability and shear elasticity) and agreement between our estimated 
mesh sizes at 3 mg/ml (~350 nm) with direct measurement of mesh size by scanning electron 
microscopy at 2.5 mg/ml (200−500 nm) (143). In these calculations we assumed a constant fiber 
length, which is consistent with measurements of low density fibrin gels (47, 48). However the 
fiber lengths in high density fibrin gels has not been measured to our knowledge. This structure-
property relationship serves as a link that can be used to estimate difficult to measure, structure-
related properties, such as permeability and hindered diffusion, from noninvasive, in vivo 
rheology measurements like ultrasound or in vitro measurements of clot mechanics like 
thromboelastogram (140, 162). Such measurements are potentially useful for guiding mechanical 
and fibrinolytic strategies.  
4.7 Conclusions 
In this study, we measured the mechanical properties of fibrin gels formed over the range 
of fibrinogen concentrations found in clots formed in vivo and used in fibrin glues and tissue 
engineering scaffolds. Shear and extensional rheology measurements show differences in the 
elastic regimes of gels formed at 3−10 mg/mL and 30−100 mg/mL fibrinogen. Interpretation of 
these results with deformation theories of fibrous networks suggests distinct network structures 
for these two types of fibrin gels.  
4.8 Supporting Material 
Materials and supplemental methods, four figures (Figs. B.1–B.4), one movie (Retraction 
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MEASURING THE PORE SPACE IN FLOW-FORMED CLOTS BY FOCUSED ION 
BEAM- SCANNING ELECTRON MICROSCOPY IMAGING 
5.1 Introduction 
Flow-formed clots have highly heterogeneous structures comprised of a dense mixture of 
cells and proteins that dictate the physical properties of a clot such as permeability, hindered 
diffusivity, and elasticity. Several studies have implicated hemodynamics as an important factor 
in regulating the role of clot growth and structure. For example, Onasoga-Jarvis et al. used 
microfluidic techniques to show that perturbations in a flow field are required to formed fibrin on 
tissue factor mimetic surfaces and that clot formation under flow results in a five-fold increase in 
fibrin concentration relative to plasma concentrations (32). Leiderman and Fogelson used 
numerical simulations for show that perturbations in the flow field due to clot growth results in 
thrombi with significant heterogeneity and that the reduced transport associated with the increase 
clot solid fraction limits clot growth to result in smaller, denser clots (34, 51). Further, a 
collection of studies utilizing a combination of computational fluid dynamic simulations and in 
vivo assays in the murine arterioles revealed that clot solid density varies radially within thrombi 
(58, 66, 163, 164). These studies identified dense “core” and less dense “shell” regions of a 
thrombus that limit the entry of plasma-borne molecules into the clot while simultaneously 
limiting the release of thrombin from within the clot. 
Several studies have shown that in vivo clots can consist of a range of protein and cell 
fractions. Histology of clots retrieved from humans with arterial fibrillation and stroke suggest 
that platelets make up 20−80% of the solids volume of the clot (96, 97). A recent electron 
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microscopy study of aspirated clots from myocardial infarction patients found that the solids 
component of thrombi consisted of 56% fibrin, 17% platelets, 12% erythrocytes, 5% cholesterol 
crystals, and 1% leukocytes (31). These studies, however, are limited in that they do not account 
for the pore space of thrombi, but instead provide a by component breakdown of only the solid 
fraction of a clot. Therefore, there exist a need to precisely determine the composition of a clot 
while preserving a measurement of both solid fraction and void space of a clot. 
In this chapter we describe a method to measure the solid fraction, porosity and pore 
structure of flow-formed clots. Microfluidic models of vascular injury were used to form whole 
blood clots on type I collagen at a wall shear rate of 100 s−1. After clot formation, the fibrin and 
platelet density in the clot is determined by confocal images analysis. Finally, a detailed map of 
the nano-scale and micro-scale structures of the of the clot is generated using a focused ion 
beam-scanning electron microscope (FIB-SEM) to section and image the internal structure of the 
clot with the void space being preserved by polymer resin embedding. Using these techniques, 
we found that the solid fraction of a flow-formed clot was 0.61 ± 0.11. Further, this technique 
allows for direct measurement of the porosity of clots and size distribution and tortuosity of the 
pore structure of a clot. 
5.2 Materials and Methods 
Thrombi were formed by perfusing whole blood over a collagen “injury” in a 
microfluidic channel. The structure of the thrombi were then quantified by confocal microscopy 
and FIB-SEM. 
 Materials 5.2.1
Human type I fibrillar collagen was purchased from Chrono-Log Corp (Havertown, PA). 
Human fibrinogen (free of plasminogen, von Willebrand factor, and fibronectin) in 20 mM 
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sodium citrate and human α-thrombin were purchased from Enzyme Research Laboratories 
(South Bend, IN). The AlexaFluor 555 labeling kit and DiOC6 (3,3’-dihexyloxacarbocyanine 
iodide) fluorescent dye were purchased from Molecular Probes (Grand Island, NY). Sodium 
cacodylate buffer (200 mM sodium cacodylate-HCl buffer, pH = 7.4), HEPES buffered saline 
(HBS; 20 mM HEPES, 150 mM NaCl, pH 7.4), recalcification buffer (75 mM NaCl, 37.5 mM 
MgCl2 in HBS ), bovine serum albumin buffer (BSA; 5 mg/ml BSA in HBS), and assay wash 
buffer (1 U/ml heparin, 7.5 mM NaCl, 3.75 mM MgCl2 in HBS), were made in house. Uranyl 
acetate, propylene oxide (PO), and the SPI-Pon 812 Epoxy Embedding Kit (SPI-Pon 812 epoxy 
resin monomer, dodecenyl succinic anhydride (DDSA) hardener, nadic methyl anhydride 
(NMA), DMP-30 Epoxy Accelerator) were purchased from Structure Probe, Inc (West Chester, 
PA). Calcium chloride, sodium chloride, magnesium chloride, and HMDS 
(hexamethlydisilazane), sodium cacodylate, fluormount aqueous mounting medium, and 
photo-grade gluteraldehyde were purchased from Sigma-Aldrich (St. Louis, MO).  
 Whole blood clot formation 5.2.2
Human type I fibrillar collagen was patterned as a 250 µm wide strip on a glass slide 
(75 mm × 25 mm) using a microfluidic channel (w = 250 µm, h = 25 µm). PDMS microfluidic 
devices for use in the flow assay were fabricated with each device having three independent 
channels (w = 500 µm, h = 50 µm, l = 20 mm). All surfaces were blocked with BSA buffer for 
1 h at room temperature prior to use.  Each channel was placed over the patterned collagen strip 
with the flow direction perpendicular to the patterned collagen direction. 
Human whole blood was collected from healthy donors via venipuncture. Phlebotomy 
was conducted in accordance with the Declaration of Helsinki and under the University of 
Colorado, Boulder Institutional Review Board approval. Donors had not consumed alcohol 
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within 48 h prior to the draw, nor had they taken any prescription or over-the-counter drugs 
within the previous 10 days. Whole blood was drawn into sodium citrate (3.2 % citrate) 
anticoagulant. For confocal assays, a fluorescently labeled fibrinogen (AlexaFluor 555) was 
added to the whole blood at an approximate molar ratio of 250:1 unlabeled:labeled. Platelets 
were labeled with DiOC6 (10 µM). After resentization for 10 min at 37°C, the whole blood was 
aliquotted for step-wise recalcification. The first aliquot of whole blood was recalcified to a final 
concentration of 7.5 mM NaCl and 3.75 mM MgCl2 with recalcification buffer. The whole blood 
was perfused over the collagen test pattern for 200 s at a shear rate of 100 s−1 in a PDMS 
microfluidic channel after which the a second aliquot was recalcified and perfused over the 
collagen. This process was repeated three times for a total assay time of 600 s (10 min). 
 Confocal microscopy of flow-formed thrombi 5.2.3
After clot formation, excess whole blood was removed from the microchannel by 
perfusion with wash buffer for 1 min. Clots were then fixed with 2% gluteraldehyde solution in 
wash buffer for 2 min. The microchannel was removed, clots were dried, fluormount added, and 
the glass slide and clot capped with a coverslip. Images were captured on a laser scanning 
confocal microscope (Fluoview FV10i; Olympus, Melville, NY) using 10x (NA 0.4) and 60x 
(NA 1.2) objectives and excitation/emission wavelengths of 556/573 nm and 495/521 nm at laser 
intensities of 20% and 40% for the AlexaFluor555 and DiOC6, respectively. 
 The platelet concentration and platelet volume fraction, ϕp, was calculated by counting 
the number of platelets within a sample volume, Vsample, of a confocal image where sample 
volume is determined by: 
Vsample = Asamplelplt  (5.1) 
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where Asample is the sample area of the confocal image and lplt is the linear distance occupied by a 
platelet. The linear distance occupied by a platelet is calculated by counting the number of 
platelets along a randomly oriented line in the image plane and assuming the in-plane platelet 
spacing is identical to the spacing normal to the image plane. Each platelet was assumed to have 
a mean volume of 8.48 ± 0.71 fL (165). The ratio of the total platelet volume (platelet number × 
platelet volume) to total sample volume is reported as the platelet volume fraction. 
 Fibrin concentration is a flow formed clot is calculated by comparing the fluorescence 
intensities of a region of interest of the flow form clot to a standard curve. The standard curve 
was created by forming fibrin gels with 3, 20, 50, and 80 mg/ml fibrin with a ratio of 250:1 
unlabeled to labeled (Alexafluor 555) fibrinogen between a glass slide an a coverslip by the 
additions of 10 nM human α-thrombin (final concentration). Images were taken using the same 
confocal microscope settings as used for the imaging of the flow-formed thrombi and the average 
image intensity recorded. 
 Resin embedding  5.2.4
After allowing the clots to form for 10 minutes, the whole blood was removed from the 
microchannels by perfusion with wash buffer for 1 min, after which the clots were preliminarily 
fixed with a 0.2% gluteraldehyde solution in wash buffer. After this initial fixing step, the PDMS 
microchannel was removed, replaced with a PDMS well, and the clot immerse in a series of 
solutions for 10 min each (unless otherwise specified) to prepare the clots for imaging with the 
focused-ion beam scanning electron microscope. Clots were immerse in: 100 mM sodium 
cacodylate-HCl buffer, pH = 7.4; 2% gluteraldehyde solution in 100 mM sodium cacodylate-HCl 
buffer (1 h); RO water (5 × 10 min); 2% uranyl acetate solution in water (1 h); RO water 
(5 × 10 min); 35%, 50%, 60%, 70%, 80%, 90%, 95% (2 × 10 min), 100%, 100% (20 min), 
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100% (30 min) ethanol in RO water; 50% PO in ethanol solution; 100% PO (2 × 15 min); 50% 
PO in SPI-Pon 812 resin mixture (SPI-Pon 812 45%, DDSA 28%, NMA 25%, DMP 2% v/v) 
(1 h); 100% SPI-Pon 812 resin mixture (48 hr) at 60˚C to allow resin to harden. After hardening 
of the resin the polymer block containing the clot was removed from the glass slide and sputter 
coated with a thin (~10 nm) layer of gold as the last step before imaging. Finally, the location of 
the clot in the resin was identified using a stereoscope and marked with a needle. 
 FIB-SEM imaging 5.2.5
Imaging was performed on a Helios NanoLab DualBeam focused ion beam-scanning 
electron microscope from FEI Company (Hillsboro OR). First, a sacrificial layer of platinum 
~300 nm thick is deposited to protect the clot and resin to be imaged from the high current 
during milling. A trench (length = 15 µm, width = 5 µm, depth = 5 µm) was then cut into the 
resin embedded clot by milling the resin at an accelerating voltage of 30 kV and 21 nA of beam 
current. After milling the cross-section of the clot was imaged at 2.0 kV accelerating voltage and 
0.69 nA beam current. 
 Area thresholding to determine solid fraction 5.2.6
The area occupied by the platelet clot was determined by performing a series of image 
processing steps using ImageJ software. The background was subtracted from the raw image 
using the Sternberg rolling ball method with a rolling ball radius that was at least five times 
larger than the largest feature visible (166). The contrast of the image was then enhanced by 
normalizing the image histogram after which the image was smoothed using a two sigma 
Gaussian blur. The perimeter of the clot was then manually selected as the region of interest and 
the image thresholded using the Default thresholding routine. To determine the area fraction of 
the thrombi while discounting the internal pore of a platelet, the area fraction is calculated by 
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discounting any pore smaller than 0.2 µm2 in area, which is roughly the area of the pore of the 
open canalicular system (167).  
 Relief contrast microscopy of clots to determine clot area 5.2.7
Relief contrast images of the clot were taken by Hoffman modulation contrast (HMC) 
(20X, NA 0.45) on an IX81 inverted microscopy from Olympus (Melville, NY) at t = 600 s 
(pre-fixed), after fixing with 0.2% gluteraldehyde but before removal of the microchannel (post-
fixed), and after resin embedding (post-embedded) to quantify any clot structural changes during 
the embedding process. Clot area calculation was conducted using the same image processing 
method used for determining the solid fraction of the milled clots. 
5.3 Results 
Thrombi formed under flow resulted in thrombi with heterogeneous structures that were 
comprised of a majority of solids. 
 Thrombus heterogeneity 5.3.1
Thrombi were formed by perfusing recalcified whole blood over type I fibrillar collagen at a 
shear rate of 100 s−1. Analysis of confocal images of a flow-formed thrombi reveals clots formed 
of dense platelet aggregates containing heterogeneously dispersed pockets of dense fibrin 
(Fig. 5.1. A). The 495/521 nm (DiOC6) channel of 300X magnification images (Fig 5.1. B) was 
used to determine both the linear distance occupied by a platelet, lplt, the platelet concentration, 
and the platelet volume fraction, ϕp, which were calculated to be 2.24 ± 0.13 µm/platelet, 
7.7 ± 1.2 × 107 Plt/µL, and 0.66 ± 0.16, respectively, based on a minimum of five measurement 
taken at least three different locations in the thrombus. Three-dimensional reconstruction of a 
series of images taken at 1 µm height increments show the morphology of the clot and reveals an 
max thrombus height of 18 µm (Fig. 5.1. C). Confocal images at h = 7 µm allows for the 
 109 
quantification of fibrin density in different regions within the thrombus, with regions of interest 
1, 2, 3, and 4 having fibrinogen concentrations of greater than 80 (above the range of the 
standard curve), 50 ± 4, 35 ± 3, and 6 ± 1 mg/ml fibrinogen, respectively (Fig. 5.1. D). 
 
 
Figure 5.1. Morphology of whole blood clots formed at 100 s-1 containing labeled fibrinogen 
(red) at a 250:1 unlabeled:labeled ratio platelets labeled with DiOC6 (green). (A) The overall 
structure of a flow-formed clot shows both platelet-rich and fibrin-rich regions. (B) Individual 
platelet are resolved with the 495/521 nm channel. (C) Three dimensional reconstruction enables 
a details map of thrombus morphology. (D) Fibrin can accumulate in dense pockets or as strands 
in between platelet aggregates. 
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 Flow-formed clots are comprised of mostly solids 5.3.2
Imaging of the cross-section of a clot formed by perfusing whole blood over fibrillar 
collage at 100 s−1 using FIB-SEM showed that flow-formed clots consist of 61% solids by 
volume. Figs. 5.2 A-D show the raw image of the sectioned clot, the background subtracted 
image, the contrast enhances image, and the thresholded image along with the region of interest 
used to determine the porosity of the clot. In addition, cross-section images reveal pore with high 
tortuosity as well as a nanometer to micrometer distribution of pore sizes. Analysis of the solid 
fraction of the cross-section in which pores smaller than 0.2 µm2 were discounted revealed the 
solid fraction of a flow formed clot when discounting the internal pores of a platelet is 0.65.  
 The embedding procedure does not alter clot geometry 5.3.3
Comparison of the areas of a flow-formed clot during different processing stages show 
that the size of the clot did not change during processing and therefore the size of the clot viewed 
with the FIB-SEM was representative of the clot size during the final stages of clot growth. The 
clot sectioned in Fig 5.2 is shown during different stages of processing along with the 
thresholded image at each stage (Fig. 5.3). During all stages of processing, the thrombus retained 
it overall shape (Fig. 5.3. A, C, E) and size with areas measured at 616, 632, and 674 µm2 for 
pre-fixed, post-fixed, and post-embedded clots, respectively (Fig. 5.3. B, D, F).  
5.4 Discussion 
The objective of this study was to develop a method to assess the structure and 
composition of flow-formed thrombi. Confocal image analysis was used to measure both the 
platelet and fibrin density as a function of position within a clot. FIB-SEM was used to precisely 












Figure 5.2. Image process steps used to derive the solids fraction of whole blood clots formed at 
100 s-1. (A) Initial image, (B) Image with background subtracted using the rolling-ball method 
with a radius of 1000 pixels, (C) Contrast-enhanced and smoothed image after subtraction, and 
(D) Thresholded image and region of interest used to determine the area fraction outlined in 





Figure 5.3. Images of flow-formed thrombi. (A) Thrombus at 10 min during flow with whole 
blood WB at 100 s-1 (B) Thresholded image of thrombus in A. (C) Thrombus at after initial rinse 
with sodium cacodylate buffer but before the removal of the PDMS channel. (D) Thresholded 
image of thrombus in C. (E) Thromus after resin embedding (F) Thresholded image of thrombus 
in E. Red rectangle highlights the thrombus selected for cross-sectioning and the dashed yellow 
line shows the approximate location of the cross-section. Scale bar = 20 µm 
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total accumulation and spatial variations of fibrin and platelets of the clot and provide detailed 
information about its the pore structure. 
Confocal image analysis revealed that platelets occupy 66 ± 16% of the total volume of a 
flow-formed thrombi based a count of the platelets with an image plane and assuming a platelet 
volume. However, platelet volume can vary both from person to person and within an individual 
which may add error to our estimate (165). Measurement of fibrin concentration revealed 
pockets of fibrin within the thrombus with as little as 6 ± 1 mg/ml fibrin and with greater 
80 mg/ml fibrin. These measurements of fibrin concentration in platelet dense thombi are made 
based on a comparison to a standard curve created in the absence of platelets which may scatter 
some of the light signal from the fibrin and result in an underestimation of the fibrin 
concentration. However, these estimates agree with measurements of the area fraction calculated 
by FIB-SEM imaging. Further, these estimates agree with in vivo measurements that determined 
the thrombus solid fraction of in vivo clots to be was roughly 0.5 by comparing the signal of 
fluorescently-labeled BSA in whole blood (with a porosity of 0.6 assuming a hematocrit of 0.4) 
to the signal within the clot during clot formation (66). 
Images of the sectioned thrombus revealed a heterogeneous pore structure with pores on 
both micrometer and nanometer scales. It is possible that some of these areas, in particular the 
smaller pores, are actually isolated pores within the platelet that are part of either the open 
canalicular system or alpha-granules that may have reacted differently to the uranyl acetate stain. 
These pores would therefore not be part of void fraction available for transport within the clot. 
Estimates of the void fraction of a thrombus may potentially need to be adjusted to account for 
this discrepancy; however, these discrepancies would be less than ± 0.04 based on calculations of 
the solid fraction with pores smaller than 500 nm filled. 
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This method will prove useful in determining the morphology of clots formed over a 
range of physiological and pathological hemodynamic conditions. For instance, FIB-SEM 
analysis can be used in conjunction with microfluidic assays to form thrombi on collagen, tissue 
factor, and collagen and tissue factor surfaces, at low (100 s−1), high (1000 s−1), and pathological 
(10,000 s−1) shear rates. Cross-sections can be cut into each thrombus both perpendicular and 
parallel to the direction of flow to determine the anisotropy of thrombus porosity, pore size 
distribution, and pore tortuosity as a function of prothrombotic surface and shear condition. 
5.5 Conclusion 
In this study, we have devised a method to quantify the structure and composition of 
flow-formed thrombi. We found that a combination of confocal image analysis and FIB SEM 
imagine allow to quantification of flow-formed clots on both the micrometer and nanometer 
scale, while also accounting for the pore space of the clot. Clots were found to be comprised of a 
greater than 60% solids with a high degree of variability in fibrin concentration. This method can 
be used to determine the precise morphology of clots formed at a large variety of hemodynamic 
conditions and will aid in delivering drug delivery strategies and in determining the mechanisms 





6.1. Summary of Results 
Thrombus formation is a complex process involving an intertwined series of events 
including platelet adhesion and aggregation, coagulation, and transport limitations that affect the 
final structure of the clot. In this thesis, the physical properties that of affect the growth, 
structure, and mechanical strength of a clot were measured at fibrin and platelets densities 
relevant to those found in flow-formed clots, and constitutive models of each properties 
dependence on fibrin and platelet density were developed. 
In Chapter 3 the hydraulic permeability and hindered diffusivity of macromolecules were 
measured in fibrin gels and thrombi representative of the composition found in vivo. Fibrin gels 
formed with fiber volume fractions ranging from 0.02−0.54 had permeabilities ranging from 
1.2 × 10−1–1.5 × 10−4 µm2. Platelet rich clots with platelet volume fractions of 0.01−0.61 and a 
fibrin volume fraction of 0.03 had permeabilities ranging from 1.1 × 10−2 to 1.5 × 10-5 µm2.  
Fibrin gels formed with a fiber volume fraction of 0.36 reduced the diffusion coefficients of 12, 
29, and 54 nm solutes by 60%, 66% and 85%, respectively. Platelet rich clots with a platelet 
volume fraction 0.61 reduced the diffusion coefficient of a 12 nm solute by 93%. The 
permeability of fibrin gels and of clots with platelet volume fraction less than 0.2 were modeled 
as an array of disordered cylinders with uniform diameters. Clots with a platelet volume fraction 
greater than 0.2 were modeled as a Brinkman medium of coarse solids (platelets) embedded in a 
mesh of fine fibers (fibrin). Hindered diffusivity of fibrin gels and platelet rich clots was 
predicted using permeability measurements and the effective medium model. Our data suggests 
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that the permeability of clots formed in vivo can vary by up to five orders-of-magnitude, with 
pore sizes ranging from 4−350 nm that significantly restrict solute diffusion. These findings have 
important implications for the transport of coagulation zymogens/enzymes in the interstitial 
spaces during clot formation, as well as the design of fibrinolytic drug delivery strategies. 
In Chapter 4 the mechanical properties of fibrin gels formed at low (3−10 mg/mL) and 
high (30−100 mg/mL) concentrations of fibrin were measured and described at low, moderate, 
and high strains using shear and extensional rheology. Confocal microscopy of the gels shows 
that fiber density increases with fibrinogen concentration. At low strains fibrin gels act as 
thermal networks independent of fibrinogen concentration. Within the low strain regime, the 
mesh size of fibrin gels can be predicted by the elastic modulus using semiflexible polymer 
theory. Significantly, this provides a link between gel mechanics and interstitial fluid flow. At 
moderate strains, we find that low density fibrin gels act as nonaffine mechanical networks and 
transition to affine mechanical networks with increasing strains within the moderate regime, 
while high density fibrin gels only act as affine mechanical networks. At high strains, the 
backbone of individual fibrin fibers stretch for all fibrin gels. Platelets can retract low density 
gels by greater than 80% their initial volumes, but retraction is attenuated in high density fibrin 
gels and with decreasing platelet density. Taken together, these results showed that the nature of 
deformation of fibrin is a strong function of fibrin fiber density, which has ramifications for the 
growth, embolization and lysis of thrombi.  
In Chapter 5 a method to assess the structure of flow-formed clots using microfluidic 
devices was described. Clots were formed by perfusing reconstituted whole blood over type I 
fibrillar collagen at a constant shear rate of 100 s-1. The structure of each formed clot was 
measured using confocal microscopy and electron microscopy using a focused ion beam to 
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section the sample. Confocal microscopy revealed that flow-formed clots has platelet dense 
regions with approximately 7.7 ± 1.2 × 107 Plt/µL corresponding to a total platelet solids fraction 
of 0.66 ± 0.16 v/v, assuming each platelet has a volume of 8.48 ± 0.71fL (165). These values are 
in agreement with value of solid fraction obtained from electron microscopy measurements of 
ion beam-milled clots, which showed flow-formed clots contain minimum solid fractions of 
0.61. These findings indicate that flow has a significant effect on clot structure and results in a 
much higher solid fraction compared to clots formed statically from platelet rich plasma. 
6.2. Future Research 
The models of the physical properties of thrombi established in this work allows for the 
predictions of properties relevant to thrombus growth and thromboembolism. Data of thrombi 
permeability and hindered diffusivity suggest that hindered transport is a mechanism of clot 
arrest. Data of thrombi elasticity suggest that fracture is a mechanism of thromboembolism. 
6.2.1. Transport mechanisms of clot arrest 
In this work, I have shown that fluid and solute transport through both fibrin gels and 
platelet rich clots is significantly hindered due to the decreased pore sizes caused by increased 
solid fractions. I hypothesize that this restricted transport serves as a mechanism to limit the 
extent of clot growth. As discussed in Chapter 2, important coagulation factors such as factor X 
and prothrombin must move from the plasma, to the interior of the clot to become activated, and 
then back to the exterior of the clot to convert additional fibrinogen to fibrin and activate 
additional platelets. The diameter of these coagulation factors are roughly 5 nm to 10 nm 
(thrombin and factor X, respectively), similar to the pore diameters of dense platelet rich clots 
and dense fibrin gels clots (4 nm and 12 nm, respectively) (168, 169). During the initial stages of 
formation, the solid fraction is small. The clot thus contains large pores that allow unrestricted 
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movement of solutes resulting in burst of coagulation and platelet activity and growth of the clot. 
As the solid fraction in the clot increases the pore size decreases to limit the introduction of 
zymogens and the exit of activated enzymes. This hypothesis has been tested and limitedly 
validated using a spatial-temporal mathematical model, with the limitations of experiments being 
the testing of only one injury size and the limitations of the model being the assumed function 
for permeability had not been validated by experimental measurements (34). Therefore, the need 
exists to test the restricted transport hypothesis in a more valid system, such as a microfluidic 
assay, where blood is perfused at a constant pressure over a prothrombotic substrate. Such 
measurements of hindered transport could then be used as a lookup table to improve 
computational methods.  
Although arterial thrombosis occurs on times scales of minutes, other types of thrombi 
can take hours or days to form. These longer time scales are characteristic of venous thrombosis 
and intraluminal thrombosis in aortic abdominal aneurysms. To accomplish these times scales 
experimentally is a challenge. One potential strategy is to draw whole blood into sodium citrate 
and then recalcify it using a chaotic mixing device to achieve on-chip steady-state recalcification 
before being perfused over a patterned prothrombotic surface (170). This chaotic mixing device 
“mixes” two streams (whole blood and recalcification buffer) by utilizing a structured channel 
pattern to induce transverse flows within the microchannel to fold volumes of fluid over one 
another thus reducing the diffusion length within the fluid. Clot growth should be measured 
during the assay using both area analysis of microscope images and velocity measurements, and 
post-assay via confocal imaging. Velocity measurement should be made by measuring the 
streaklines of fluorescently labeled beads at a location upstream of the clot in a manner similar to 
previously described methods (171). Clots should be allowed to form at a series of shear rates 
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(150, 300, 750, 1500 s−1) until either the channel becomes occluded or until the velocity in the 
channel remains constant, indicating no further change in the size of the thrombus. Post-assay, 
the total volume and solid fraction of each flow-formed thrombi can be measured using confocal 
and FIB-SEM imaging. From this set of experiments one would be able to identify the growth 
limits and corresponding solid density of clots as a function of shear rate, injury size, and 
channel size. Additionally, this experiment could be extended to test flow-regulated clot growth 
as a function of hematocrit, platelet count, and plasma concentrations of coagulation factors. 
6.2.2. Structures and mechanisms of thromboembolism 
Thromboembolism is a major concern in the area of thrombosis, and occurs when a 
thrombus or part of a thrombus becomes dislodged, travels downstream, and blocks a vessel at a 
new location. Thromboembolism can result in blockages of the main arteries to the heart, brain, 
or lungs causing myocardial infarction, stroke, or pulmonary embolism, respectively. In 
Chapter 4, the mechanical properties of fibrin, the biopolymer responsible reinforcing the 
strength of a thrombus, was measured and characterized. These experiments revealed that the 
strength of all fibrin gels tested far exceeded the stresses typically encountered in a vessel. 
Assuming a high physiological shear rate of 1600 s−1 and a blood viscosity of 0.003 Pa s, the 
highest stress typically encountered in a vessel can be calculated to be 5 Pa (τ = η×γ). This stress 
is far lower than the breaking strength of a 10 mg/ml fibrin gel which was found to be on the 
order of 10,000 Pa. Further, the elastic modulus of a 3 mg/ml at 1% strain was found to be on the 
order of 100 Pa, suggesting that the typical stresses encountered in a vessel should only 
minimally strain a thrombus, and should be incapable of causing thromboembolism. 
Nevertheless, thromboembolism continues to exist as a major problem. 
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I hypothesize that in order for a thrombus to embolize, the stress imparted on the clot by 
the flow must be concentrated into a small region of the clot. This stress concentration causes a 
fracture to develop, leading to an increased stress in the area immediately surrounding the initial 
break, which further propagates and ultimately leads to thromboembolism. This mechanism of 
failure is typical in materials where the elastic modulus exceeds the cohesive strength (stress at 
failure) of a material (172). Results from Chapter 4 revealed that the cohesive strength of a 
10 mg/ml fibrin gel was similar to the elastic modulus of a 100 mg/ml fibrin gel. Therefore, 
spatial variations in the structure of a thrombus could result in a condition under which a small 
initial “crack” would propagate. Further, several studies have indicated that atherosclerotic 
plaque rupture is triggered by high-stress regions that develop into fractures due to spatial 
variations in the plaque structure (173, 174). Similarly, flow-formed thrombi often form with 
structural variations. Magnetic resonance imaging and immunohistochemistry consistently 
showed that ex vivo pulmonary emboli and thromboemboli were heterogeneous in structure and 
contained both a fibrin and RBC-rich region and a separate platelet-rich regions (11, 175). Due 
to the heterogeneous structure of a thrombus and the large range of possible mechanical 
properties associated with a variable structure, fracturing is a likely mechanism of failure of 
flow-formed thrombi. 
The property that describes resistance to fracturing is in elastic materials is known as 
fracture toughness or the material’s J-integral, Jlc., and is a measurement of the energy required 
to grow a thin fracture in a material. Fracture toughness can be measured in three differing 
shearing modes (I, II, and III) corresponding to tensile, shear, and tearing loads, respectively, 
with the tensile and shear modes being the most likely modes of thromboembolism. 
 121 
To determine the feasibility of this hypothesis both the nonaffine behavior and the 
fracture toughness of model thrombi should be tested as a function of fibrin, platelet, and red 
blood cell concentration. In traditional composite material, stiffer regions embedded in a soft 
fiber matrix can generate a nonaffine strain field which could lead to stress concentrations in the 
material (159). Therefore, any nonaffine behavior would indicate the likelihood of a stress 
concentration leading to the initiation of a fracture. Nonaffine mechanical testing should be 
conducted using the methods described in chapter 4; the extend of nonaffine deformations should 
be mapped out as a function of platelet and RBC fractions by analyzing the ratio of shear to 
normal stress and E(γ)/G(γ) to determine which concentrations of cell components help distribute 
or concentrate stress. The likelihood of fracture propagation should then be tested for each model 
thrombi according to the American Society for Testing and Materials (ASTM) test E1820-01 
(176). Briefly, samples formed at each previously mentioned combination of components should 
be cast between two glass slide and cut into strips in a manner previously described in chapter 4. 
After creation of the test strips, a notch should be cut into the sample to a depth of one-half of the 
sample width with a razor blade. After notching the sample should be mounted to the ARES-G2 
and extensional test performed on the Sentmanat fixture and a stress and fracture length 
measured as a function of strain to obtain a value for each thrombi’s fracture toughness. The 
value of fracture toughness obtains can then be used to estimate if a stress less than the failure 
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SUPPLEMENTAL INFORMATION FOR CHAPTER 3 
A.1 Derivation of permeability between two platelet embedded in a fibrin mesh 
This derivation is presented in Example 8.7 on p. 417 of Truskey et. al and is shown here 
in terms of the variables defined in the manuscript text (72). Consider the case of two parallel 
plates separated by a distance h that represent two platelets with a fibrin gel between them 
depicted above. There is an interstitial flow of fluid with a viscosity µ and a mean velocity of U 











= 0  (A-1) 
where vx is the velocity in the x-direction and P is the pressure. Note that vx is only a function of 
y and the pressure gradient is only a function of x. The boundary conditions are no-slip at the 
platelet surface and symmetry at the midline: 
 
Figure A-1. Schematic of the space between two platelets. Platelets are modeled as two parallel 
plates with the space between each plate filled by a fibrin gel. 
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vx = 0 at y = h / 2
dvx
dy
= 0 at y = 0
  (A-2) 







cosh y / k f( )









  (A-3) 
The mean velocity can be calculated by: 
U = 1
h



























∫   (A-4) 
Finally, the total permeability between the two plates is defined by the ratio of the mean velocity 
and the pressure gradient (kt = µU/(dP/dx)): 





















  (A.5) 
A.2 Validation of 2D FRAP Approximation 
The following study was conducted to determine if 2D analysis of fluorescence recovery 
after photobleaching (FRAP) is valid to analysis of the diffusion coefficients in 3D fibrin gels. 
A.2.1 Introduction 
Fluorescence recovery after photobleaching (FRAP) is often used to measure diffusion 
coefficients in lipid bilayers.  The solute to be measured is tagged with a fluorophore.  After an 
initial image is captured, the fluorophores within a region of the bilayer is quickly bleached with 
a high powered laser.  After bleaching, the molecules within the bilayer are allowed to diffuse 
throughout the sample.  The diffusion of fluorescent molecules into the bleached region is found 
by measurement of the fluorescent signal within the region over time.  This technique has been 
so successful that programs have been written that analyze FRAP images and automatically 
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calculate diffusion coefficients even in non-ideal samples (convection, uneven illumination, 
diffusion while bleaching) (99).  One drawback to this program is that it is designed to analyze 
2D diffusion; however, if the extent of bleaching in the z-direction is much greater than the 
sample thickness the 3D situation behaves like the 2D situation and programs designed to 
analyze 2D diffusion can be used (177).  The purpose of this work was to test if a 2D analysis 
can be used to analyze FRAP measurements in platelet rich thrombi and fibrin gels 
A.2.2 Materials and Methods 
Fibrin gels and platelets rich thrombi were formed with 0.02 mg/ml of 500 kDa FITC 
dextran included in the sample.  Before bleaching, the sample thickness is measured by finding 
the focal planes at each end of the sample with a confocal microscope (Olympus Fluoview 
FV10i).  After measurement a z-stack was taken of the pre-bleached sample with a 10x objective 
and a z-spacing of 10 um.  The sample was then bleached at 100% laser power and 3x optical 
zoom by setting the focal plan to the center of the sample with the confocal aperture wide open 
(5.0x) for 5 min.  After bleaching a z-stack was taken of the entire sample.  The extend of 
bleaching through the sample was determined by measuring the fractional decrease in fluorescent 
signal as a function of z-plane through the sample according to Eqn. A-6, where FD is the 
fractional decrease of signal, Ipost is the post-bleach signal and Ipre is the pre-bleached signal. 
FD =
I pre − I post
I pre
  (A-6) 
A.2.3 Results 
In all cases, sample thickness was between 40 µm and 50 µm.  The measured fractional 
decrease in fluorescent signal for a 5 min bleach was roughly 0.33 in all cases.  Table A-1 shows 
the factional decrease in signal for two different samples of platelet rich thrombi.   
 139 
A.2.4 Discussion 
According to Braga et al, if the sample thickness of sample is less than the finite axial 
size of the bleached volume then the 3D sample will behave like its 2D counterpart.  Because the 
extent of bleaching in our samples roughly constant through the entire sample (doesn’t decrease 
in the z-direction over the entire sample thickness) 2D FRAP analysis can be used to measure 
diffusion coefficients in fibrin gels and platelet rich thrombi provided that the sample thickness is 
< 50 µm and that the numerical aperture is open to allow the laser to pass through the sample as 
a column as opposed to a cone.  It should be noted that this 50 µm criterion is set only because 
that was the range that was tested.  The actual value of extend of bleaching for this system my in 
fact be larger. 
A.2.5 Conclusion 
The 2D FRAP analysis and subsequent Matlab routine used in Jonsson et al. provides 
valid assessment of the diffusion coefficients in fibrin gels. 
 
Table A-1. Fractional Decrease in fluorescent signal as a function of z-distance within the bleached 
sample. 
Distance from center of sample 
[µm] 7×106 Plt/µL 2×107 Plt/µL 
-20 0.30 0.36 
-10 0.31 0.35 
0 0.31 0.34 
10 0.32 0.33 




Figure A-2. Experimental set-up for measuring clot permeability. A reservoir containing TBS 
supported by a ring stand and clamp was connected to the top of the permeation chamber via an 
8 mm ID Tygon® connecting tube.  0.76 mm ID silastic tubing was connected to the bottom of 
the chamber via a blunt 16 gauge needle. The volumetric flow rate of buffer through the fibrin 
gel or platelet rich clot was calculated by measuring the displacement of the air-buffer interface 
in the tubing at regular time intervals.  (Insert) Image showing permeability measurements of 






Figure A-3. Image analysis for obtaining measured platelet area fractions. (A) Original 600x 
magnified confocal image showing only the platelets (green) of a PRC at a density of 4×107 
platelet/μL. Scale bar = 20 µm. (B) Original image converted to 8-bit grayscale with ImageJ 
software.  (C) Greyscale image after subtraction of the background using the Sternberg rolling 
ball method with a rolling ball radius of 10 μm.  (D) Final image after thresholding with a 





Figure A-4. Solutions for the normalized permeability of the Brinkman equation from Ethier 
(115).  The total permeability, kt, is normalized by the permeability of the fine fraction, kf. In our 
case, the fine fraction refers to the fibrin. Each line represents a different ratio between the fine 
fraction permeability and the square of the radius of the coarse objects (kf/acoarse2): 10 (− −), 1 










Platelet Solid Fraction, φp
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Figure A-5. The effect of platelets on fibrin fiber morphology. The presence of platelet (A, C) 
leads to shorter fibrin fibers compared to platelet poor plasma (B, D). The volume fraction of 





SUPPLEMENTAL INFORMATION FOR CHAPTER 4 
B.1 Modified Clauss Assay  
 Ten milliliters of stock fibrinogen solution at 12.9 mg/ml were dialyzed against TBS 
and then reduced to ~1 mL by centrifuging the solution at 37ºC in a centrifugal concentrator 
device with a molecular weight cutoff of 100,000 Da. The concentration of the resulting retentate 
solution is ~129 mg/mL fibrinogen. A sample of this concentrated solution is diluted to 
~1 mg/mL in TBS and 10 nm thrombin and 2.5 mM CaCl2 (final concentrations) are added to 
induce gelation. The absorbance of this gel is measured at 405 nm and compared to a standard 
curve (dynamic range 0−1.5 mg/mL) to determine a more accurate concentration of the diluted 
sample. The initial estimate for the retentate solution concentration (129 mg/mL) is then refined 
based on the measured concentration of the diluted sample (e.g. if the diluted sample was 
determined to have 1.05 mg/ml fibrin instead of 1.0 mg/ml fibrin the initial estimate would be 
scaled by 1.05/1 to give a value of 135 mg/ml).  
 To validate this method, we compared value the concentration of fibrinogen as 
determined by the modified Clauss assay to the concentration of a 400X diluted retentate sample 
as determined by absorbance at 280 nm using a UV/VIS spectrophotometer with an extinction 
coefficient of 1.51 mL mg-1 cm-1 (178). The concentrations of the fibrinogen retentate as 
determined by the modified Clauss assay (129 ± 4 mg/ml) was found to be in good agreement 
with the value determined by UV/VIS (125 ± 2 mg/ml).  
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B.2 Solubility of fibrinogen solution 
One hundred microliters of concentrated fibrinogen (~130 mg/ml) and fibrinogen stock 
solution (12.9 mg/ml) were pipetted into the wells of a clear, flat-bottomed 96-well plate. 
Solutions were incubated at 4, 20, and 37 ºC and the absorbance at 450 nm of was measured over 
a period of 45 h to determine solubility (179). Each condition was done in triplicate. The 
absorbance of both the concentrated fibrinogen and the stock fibrinogen incubated at 4°C 
increased with time indicating precipitation of fibrinogen (Fig. B-2). This precipitation was also 
observed by transition from a clear to cloudy solution. The absorbance of the same fibrinogen 
solutions incubated at 21°C and 37°C did not change of over the period of 45 hours indicating 
the fibrinogen remained in solution. 
B.3 SDS-PAGE Analysis of Fibrin Cross-linking 
Fibrin gels identical to those use in the mechanical testing experiments were formed with 3, 10, 
30, 50, and 100 mg/ml fibrinogen and 10 nM thrombin (final concentrations) and allowed to gel 
for 50 minutes. Ligating reactions in the samples was quenched with 6 M urea, and 2% SDS at 
37ºC for 2 h. Gel electrophoresis (8% polyacrylamide) was prepared using standard protocols 
(180). Briefly, to make one gel, 1.6mL 40% acrylamide solution, 2 mL 1.5M Tris buffer, 80 µL 
each of 10% SDS solution and 10% (by weight) of APS solution and 8 µL of TEMED to 4.2mL 
of deinonized water. The solution was mixed, cast into a mini gel 1 mm thick and allowed to 
polymerize for 45 minutes. Samples for electrophoresis were prepared by diluting proteins to 
~12 µg of total protein in deionized water and adding 4x Laemmli loading buffer (1:3 loading 
buffer:sample). Total volume of ~25 µL of sample was loaded in each well. Proteins were 
fractionated into bands by electrophoresis running at 110 V for 90 minutes. Protein bands were 
visualized by staining with Coomasie blue stain for 1.5 h followed by washing in deionized 
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water. The gels were then imaged on an Alpha Innotech IS2200 digital UV-Vis imaging system 
(Santa Clara, CA). Fig. B-3 shows the results of the gel and demonstrates cross-linking for all 
fibrin gels.  
B.4 Confocal microscopy of fibrin gels  
Fibrin gels were prepared for confocal microscopy were prepared exactly as described above, 
except that samples were formed between glass slide and a #1 glass coverslip. Fibrinogen was 
labeled with AlexaFluor® 555 according to the manufacturer’s instructions and was added to 
each solution at a molar ratio of 500:1 unlabeled:labeled fibrinogen. Images were captured on a 
laser scanning confocal microscope (Olympus Fluoview FV10i) using a 60X objective 
(NA = 1.2) and excitation/emission wavelengths of 556/573 nm.  
B.5 Supporting Calculations 
The following calculations were used to calculate the bending and stretching moduli of 
fibrin and to estimate the nonaffine-affine transition. 
B.5.1 Calculating the bending modulus of an individual fibrin filament 
The persistence length of a bundle of fibers relative the persistence length of the sub-




χ 2 N −1( )
















where, κB, is the bending modulus of the bundle, κf, is the bending modulus of the sub-filament, 
N, is the number of sub-filaments or protofibrils, α, is a fiber coupling parameter, c, is the wave 
number, and χ is a parameter accounting for the finite thickness of the crosslinks. For the fully 
decoupled (no cross-linking) case, α = 0 causing the bracketed term to be equal to unity. 
However, fibrin fibers are cross-linked by factor XIIIa in our rheology measurements (Fig. B-3). 
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The bending modulus of coupled (cross-linked) and decoupled (not cross-linked) fibrin filaments 
has been reported as 14.5 MPa and 1.7 MPa, respectively (134). Based on these values, we 
estimate the bending modulus of a fibrin filament to be 8.5 times greater (14.5/1.7) than the 
bending modulus of a bundle of fully uncoupled sub-filaments, reducing Eq. B-1 to: 
κB = 8.5Nκ f  (B-2) 





where Φint, is the internal volume fraction of the fibrin filament, and ρm and µp are the mass 
density and the mass to length ratio of a protofibril, equal to 1.4 mg/ml, and 340 kDa/22.5 nm, 
respectively (112). The value for R used is the previously measured hydrated fiber radius (146). 
The internal volume fraction, Φint, is a function of fibrinogen concentration and is based on a fit 
of the data presented in Fig. 5 in Weigandt et al.(86): 
Φint = 0.015ln cfbg( )+ 0.13  (B-4) 
Using the above values, N = 30 for the filaments within out network. 
Finally, we are able to estimate the bending modulus of a fibrin filament based on the persistence 
length of a protofibril. The bending modulus of a protofibril is related to persistence length of a 
protofibril by: 
κ f = Lp, f kBT  (B-5) 
where Lp,f  is the persistence length of a protofibril previously measured to be 500 nm (81). We 
can then estimate the bending modulus of a fibrin filament to be  by combining 4.5 × 10−25 Nm2
Eqns. B.2-B.5 to obtain 
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κB = 8.5Lp, f NkBT  (B-6) 
B.5.2 Estimating the nonaffine-affine transition of fibrin gels as a function of fibrinogen 
concentration 
The nonaffine-affine (NA-A) transition length for fibrous networks can be predicted 
based on the filament length, Lc, mesh size, ξ, filament stretching modulus, µ, and filament 
bending modulus, κB (181). Affine deformations become more favorable when filament length 











Therefore, if Lc/λNA >> 1 an affine, stretching dominated regime is expected whereas if Lc/λNA 
<< 1 a nonaffine, bending dominated regime is expected. The stretching modulus, µ, is estimated 
to be 5 nN by assuming the stretch modulus of a filament is equal to the sum of the stretch 
modulus of the protofibrils within the bundle. This value is consistent with a previous estimate of 
(29)~10 nN for fibers with slightly larger diameters . The stretch modulus of an individual 
(28)protofibril is estimated to be 1.70 × 10−10 N with a corresponding length of 80 nm , assuming 
30 protofibrils per bundle (N = 30), giving µ of 5 × 10−9 N. Using this value and the value for 
, the characteristic bending length, Lb, of a fibrin filament bending modulus calculated previously
is calculated to be 30 nm. Combining Lb with estimates of mesh size as determined by 
permeability experiments allows us to calculate the NA-A transition length for each gel tested. 
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B.5.3 Estimating displacement of a fibrin caused by the platelet contractile force 
The centerline bending displacement, δbend, caused by a force imparted on a simply supported 






where Fplt is the maximum contractile force of a platelet, κB is the filament bending modulus, and 
length of bending is assumed to be the mesh size, ξ, of the network as calculated by permeability 
experiments (146). 





where Lstretch (80 nm) and µ is the stretch modulus ( ) as calculated in the previous 5 × 10−9 N
section above. Using equations B.9 and B.10, we are able to estimate the displacement imparted 
upon a fibrin fiber by a platelet assuming a platelet contractile force of 4 nN on a substrate with 
(139)elasticity of 10 kPa . An assumption in this calculation is that the bending and stretching 
 moduli hold over the range of strains predicted.
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B.6 Supporting figures 
  
 
Figure B-1. Measurement of engineering stress and calculation of E(γ) of a 100 mg/ml fibrin gel 
formed with 10 nM thrombin. (A) The biaxial stress-strain data with the moving average (---), 
and 5th degree polynomial fit (—). The shaded region represents the standard deviation (n=5). (B) 
Bi-axial stress-strain data zoomed in to show the fit at low strain. (C) E(γ) calculated as the first 



















































Figure B-2. Absorbance of fibrinogen at 450 nm as function of time of (A) Stock fibrinogen 
solution (12.9 mg/mL) from the supplier and (B) concentrated fibrinogen at 130 mg/ml for 
solutions incubated at 4 (u), 20 (n), and 37 °C (!). Increases in absorbance are indication of 




Figure B-3. Reducing SDS-PAGE analysis of fibrin gels cross-linking. Lane 1: molecular 
markers, lane 3: fibrinogen, lane 4: fibrin 3 mg/ml, lane 4: fibrin 10 mg/ml, lane 5: fibrinogen 
30 mg/ml, lane 6: fibrinogen 50 mg/ml, lane 7: fibrinogen 100 mg/ml. Bands at 66, 53, and 
47 kDa corresponding to the α, β, and γ chains of the fibinogen monomer The band at 100 kDa 
corresponding to the γ-γ dimer. All fibrin gels (3 – 100 mg/ml) showed the bands at 100 kDa 
corresponding to the γ-γ dimer indicating that all gels underwent γ-chain crosslinking. Gels 
formed with 3 – 50 mg/ml showed the absence of the 47 kDa (γ) band indicating that these gels 
were completely γ-chain crossinked. Both the 100 kDa (γ-γ dimer) and the 47 kDa (γ-chain) 
were present for the 100 mg/ml gel indicating that this gel was crosslinked, but the extent of 
crosslinking is unknown. All gels showed bands at the very top of the well corresponsing to αn 
polymer segments. The presence of bands at 66 kDa (α) in all gels show that α-chain 
crosslinking is incomplete in all gels. 
 
Figure B-4. Representative G’ as a function time for a 100 mg/ml fibrin gel formed with 100 nM 
thrombin showing the lag, growth, and steady phases. 
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APPENDIX C 
SUPPLEMENTAL ELECTRONIC FILES 
 Included is one video exhibiting the retraction of fibrin gels derived from 3, 10, and 
30 mg/ml fibrinogen and 10 nM thrombin with the inclusion of 2×104 and 2×105 platelets/µL at 
37 °C over the course of 5 h. 
Retraction Movie.mov Quicktime file containing timelapse images of 
clot retraction 
 
 
